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Within the last ·briO decades the consumer market 
has been deluged v.,rith a diversity of aerosol products. The 
accepta.bilit;y and utility of these products is reflected by 
the number found in the householc1 and industry .. 
--=R'-"e-'=lati v~j.y_f ew __ PDC3._rm_a.c~1J.tj__cg._l _ 9,E3J:'OSQls }1ay_9 l:'Qa_cht2.d ________ _ 
the market., A survey, conducted by the Peerless Tube 
Company representing eighteen pharmaceutical firms, con-
cluded that both the pharmaceutical industry and the general 
public need more aerosol information (1).. The gro·wth of the 
aero-sol as a .dosage form depends, to a large extent, on the 
ability of the product to provide advantages equal or supe-
rior to conventional dosage forms (2). 
The emulsion system has long been utilized in oint-· 
ment and cream dosage forms for topical use. Kanig (3) 
has stated that "emulsions have offered the greatest oppor-
tunity for new and useful applications of pressurized 
systems. The principles which control conventional emulsions 
are easily applicable to aerosols." These emulsion systems· 
can be easily designed to produce foam type products. 
Furthermore, the composition of these foam producing sys-
tems can be altered readily to accommodate a wide range of 
incorporated topical medicinal agents. 
Of the topical adjunctive medicinals available, the 
antibiotics, as a class, prove very useful and advantageous 
therapeutically (4-9). Antibiotics have been incorporated 
2 
into a number of ointments, creams, and lotions.. A few 
antibiotic-corticosteroid sprays and foams have been mar-
keted. At present, there are no aerosol foam systems, 
produced commercially, which contain antibiotics alone (30). 
Thus, the development of aerosol foams containing 
antibiotics would prove to be an advantageous scientific 
endeavor to supplement the therapeutic topical dosage forms~ 
The feasibility of such a project can be realized 
readily by consideration of the advantages of an antibiotic 
foam as compared to an antibiotic containing ointment or 
cream. An ant;ibiotic foam vJould obviate the necessity of 
manual application as is the case with the ointment or 
cream type products. Therefore, there would be less irri-
tation to the already traumatized or infected sites by 
mechanical, chemical, or bacterial vectors (10). 
Thus, the objective of this research project will 
be to systematically develop suitable aerosol foam systems 
- which contain therapeutically effective topical antibiotics 
with a subsequent evaluation of their properties. 
LITERATURE 
Histor;y: 
The aerosol age in which man no"' lives traces its 
origin to as early as 1862G For it was in this year that 
the first patent relating to aerosol technology, as it is 
de~ined--today-,-v-la-s -i-ssu-ed. Various-succeedi.ng -pa~tents ------------
were issued. which further augmented the science and tech-
nology of aerosols (11)8 
It was·not until the early years of \llorld War II 
that the aerosol field received its prime stimulus~ This 
was achieved. through the work of Goodhue and Sullivan who 
developed a portable, pressurized insecticide to be used by 
the Armed. Forces. The product was a bulky, av1kward, high-
pressure device which used dichlorodifluoromethane as the 
propellant (11). 
Through the efforts of the container manufacturers 
and the du Pont Company, a low-cost container and lovT-
pressure propellant provided the impetus for general con-
sumer utility. Thus, aerosol science and technology 
stimulated the market which created the aerosol age as it 
is known today (11). 
The Aerosol Foam 
An aerosol, as defined in colloid chemistry, is an 
assemblage of small liquid or solid particles, with radii 
less than about 50 microns, which are suspendeo. in air or 
a gas. Thus, this general term includes such substances 
as fog, dust, or smoke (12). Initially this definition \l!aS 
adopted by the aerosol industry~ 
4 
Today the definition of an aerosol has been expanded. 
According to the most recent definition 
approved by the Aerosol Scientific 
Committee of the Chemical Specialties 
Manufacturers Association, an aerosol 
or pressurized product may be a liquid, 
~~----- --~--solid, gas, o~mi}±ure-thereof dis-
charged by a propellant force of lique-
fied and/or nonliquefied compressed gas, 
usually from a disposable type of dis-
penser through a valve (11). 
1 
I 
I1'oams are also included in the realm of colloidal 
chemistry. As defined by Sanders (11), 11 a foam consists 
of a coarse dispersion of a gas in a liquid in which the 
volume of gas is considerably larger than that of the 
liquid." From the standpoint of the aerosol chemist, the 
. ' 
dispersed gas is the vaporized propellant and the liquid 
is the concentrate placed in the aerosol container •. The 
term concentrate, as it pertains to this project, is either 
an emulsion - a: colloidal dispersion of a liquid in a liquid, 
or a suspension - a colloidal dispersion of a solid in a 
liquid (11). 
Hence, the aerosol foam is a self-contained product 
packaged under pressure, which upon release from it;s con- · 
tainer p~oduces a coarse dispersion of vaporized propellant 
in a liquid matrix. 
~~~g]l_Eoam SY-stem Components 
The aerosol foam system is composed of essentially 
.four components: the container, the valve assembly, the 
propellant, and the concentrate or product system. 
1. The Container 
The aerosol foam container must be capable of with-
standing the internal pressure required to dispense the 
product properly and must be able to hold the product with-· 
1:------------------ - ---- --- ------- -- --
_out Q.eteriora.tion during the required shelf life.. Besides 
these essential functions, the container must be aestheti-
cally appealing and economically marketable (13,14). 
Materials used for containers include: tinplate, 
aluminum, glass, and plastic.. The most commonly used con-
tainer for general pressure and foam packaging is the 
three-piece tinplate container. As a metal, tinplate is 
a carbon steel alloy, available in different gauges with 
varying quantities of tin on the surface. These three-
piece side-seamed containers are available in sizes from 
three to twenty-four ounce capacities. They are the least 
expensive of the containers and effectively meet Federal 
pressure specifications. Also available are two-piece 
drawn cans, but these are more expensive. Aqueous-based 
products, such as some aerosol foams, where corrosion is 
a stability factor, may still be dispensed in these tin-
plate containers. This is made possible by the use of an 
internal coating with lacquers, epons, epoXys, phenolics, 
or vinyls. With the appropriate coating, a normally 
5 
corrosive product can be maintained for its desired shelf 
life (11, lL~). 
The next most popular container is the glass con-
tainer. It has found use for some small volume pharma-
ceutical foams. However, its most extensive use has been 
for cosmetic products.. The aesthetic appeal of the glass 
container has accounted for this vlidespread use by the 
cosmetic in,dustry. Besides this appeal, the inertness of 
i}--------------------------------- --- -------- --------------
the material lends itself to "~:That might be considered the 
6 
ideal container. The glass bottle is available in a 
variety of capacities, colors, and shapes., The chief dis-
advantages of the glass container are its breakage potential 
and its cost. Breakage now, has been minimized by use of a 
plastic coating consisting o:f thermoplastic polyvinyl chlo-
ride. The coating retains glass fragments should it break 
(11,14,15). 
Aluminum containers, although used eA~ensively in 
some European countries, have not been as popular in the 
United States. This has been attributed to the higher cost 
differential of aluminum· to tin. Aluminum is \'Tell adapted 
to ext;rusion for seamless containers and is very light\lreight. 
However, besides cost, aluminum has a lower tensile strength 
as compared to the tinplate (11,14). 
The ne\'Test container material is plastic _ (15). A 
plastic container would provide many advantages. It. \'lOuld 
be aesthetically appealing, corrosion resistant, unbreak-
able, lightweight, and easy to design. The chief 
7 
disac:lvantage along with cost would be permeability to both 
exogenous and endogenous gases. Other disadvantages may 
includ.e: attack by concentrate substances, pressure limi ta-
tions, and migration of the plasticizer from the plastic, 
thereby changing the appearance and texture of the container~ 
Some materials used for plastic containers have been mela-
mine, phenolic resins, nylon, acetal copolymers, polypropyl-
ene, and linear polyethylene (11,14,15). 
0------------------- -- -------------
2. The Valve Assembl~ 
The second component of the aerosol foam system is 
the valve assembly. The valve system must be leakproof and 
non-ciogging. It must provide for proper foam discharge 
characteristics and perform efficiently for the required 
life of the product (13). For aerosol foams, two basic 
-. 
valve assembly designs exist, although modifications of 
these basic designs have been implementea .• 
The foam valve or nozzle dO\'l!l valve, as it is 
called, has been widely used in both food and the toilet-
goods industries. This valve assembly can be used for 
extremely viscous products. An aerosol foam system equipped 
with a foam valve must be inverted with the nozzle down to 
insure product discharge, for this valve type possesses no 
dip tube. The foam valve is equipped with a large internal 
orifice and a stem with a large expansion chamber. This 
large chamber enables the .propellant to whip the product 
concentrate into a foam. System integrity is maintained 
by a gasket seal which fits tightly against the valve cup. 
0 
Displacement of the valve stem deranges the gasket seal 
and allO\'lS product escape. The gasket seal is commonly 
made of buna or crepe rubber (16,17). This assembly is 
indicated in Figure 1. 
The second basic valve assembly is the stream valve 
\vith .foam actuator. This valve assembly is simply a modi-
fied standard aerosol valve, in which the spray nozzle has 
been replaced with a foam actuator. It possesses enlarged 
orifices and chambers. Products of lOi'ler viscosity are 
well suited for dispensing by this valve system. Foam 
systems equipped with this valve may be discharged in an 
upright position. Upright dispensing is made possible by 
a dip tube 't'lhich extends into the product., When the foam 
actuator is depressed the value stem displaces a gasket 
and spring, opening a body orifice and causing the pro-
pellant to force the product through the dip tube outwards. 
The product, upon reaching the expansion chamber in the 
foam actuator is \'lhipped into· a foam by the volatilizing 
propellant (16,17). This is illustrated in Figure 1. 
3. The Propellant 
8 
The third component of the system is the propellant -
the source of energy for the aerosol foam. The purpose of 
the propellant is to enable total discharge of the aerosol 
·, 
concentrate. Inadequate amounts of a propellant in a formu-
lation \tlOuld hinder marketability of a potential product. 
Available for foam products are the compressed gas 
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The compressed gas propellants are exemplified by 
such gases as nitrous oxide, carbon dioxide, ana. nitrogen • 
. These propellants have been used for both food and non-
food foam products.. Their physical state in the aerosol 
container is gaseous, although nitrous oxide and carbon 
dioxide may exhibit partial solubility in some products 
and thus behave as soluble liquefied propellants. In 
general, the container pressure produced by these propel-
il------------------ ---- ----- ---
lants depends on the amount of gas charged into the con--
tainer. The pressure produced initially \'Till decrea.se as 
the product is used, however, proper formulation and valve 
selec·tion will minimize this loss. One distinct advantage 
of these propellants is their nonflammability (13). 
Liquefied propellants form the second major cate-
gory of propellants. These exist in a liquefied state in 
the containers. They are soluble, insoluble, or emulsible 
in the product. In the container, these propellants exert 
a vapor pressure characteristic of the specific propellant 
and possess the distinct advantage of maintaining this 
pressure throughout the entire life of the product (13). 
This category may be divided into flammable and non-
flammable propellants. 
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The straight hydrocarbons such as propane, iso-
butane, and butane are flammable propellants. Theyare 
relatively lov1 in cost, being slightly more expensive than 
the compressed gases·. These propellants have not b~en used 
extensively by themselves, but·have been used in propellant 
blends. Isobutane blends have been used for aqueous 
emulsion systems (11,13). 
The fluorocarbons and chlorinated hydrocarbons 
comprise the nonflammable liquefied propellants. The 
chlorinated hydrocarbons, such as methylene chloride and 
trichloroethane, are not readily used for their propel-
lant properties, but rather for their solvent and vapor 
pressure lowering characteristics (13).. The remaining 
1}----------
group, the,- fluorocarbons, or fluorochlorohydrocarbons, 
are the most extensively used propellants by the aerosol 
industry and are the major propellants used for pharma~ 
ceutical production (18). 
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The fluorocarbons, as with all liquefied propel-
lants, are soluble, insoluble, or emulsible in the product .. 
Thus, either two-phase or three-phase systems are produced. 
Tvm-phase syst.ems exist when the fluorocarbon is either 
soluble or emulsible in the product concentrate. Three-
phase systems result when the propellant_is insoluble or 
incapable of being emulsified. 
Of these halocarbons, "three single compounds 
account for well over 95 percent of the total propellant 
_usage. These compounds are dichlorodifluoromethane, 
trichloromonofluoromethane,-and dichlorotetrafluoroethane" 
(19). These are Propellant 12, Propellant 11, and 
Propellant· 114, respectively. In the United States these 
compounds are available from the follm·ring: E. I. du Pont 
de Nemours and Company by the trade name of Freon; General 
Chemical Division of Allied Chemical and Dye Corporation 
by the trade name of Genetron; the Industrial Chemicals 
Division, Pennsalt Chemical Corporation as Isotron; and 
from the Union Carbide Chemicals Company, Division of 
Union Carbide Corporation as Ucon. Foreign manufacturers 
with their trade names include: Farbwerke Hoechst A .. G .. , 
West Germany as Frigen; Imperial Smelting Company, Ltd~, 
England as Isceon; duPont Company of Canada, Ltd~, Canada 
--------- -------------------------- --------------- ---------------
as Freon; and others (19). 
United States manufacturers of fluorinated hydro-
carbons have adopted a standard numbering system to 
specifically define the empirical and structural formulas 
of these compounds. The formulas are deliniated from the 
propellant numbers by the following rules: (11) 
12 
1. All propellants are represented by three num-
bers. In the case of a two-digit number, a zero is implied 
before the first number on the left. 
2. The first digit on the right represents the 
total number of fluorine atoms in the structure. 
3. The second digit in the sequence is one more 
than the number of hydrogen atoms in the compound. 
4. The third digit from the right is one less 
than the number of carbon atoms in the compound. 
5. The number of chlorine atoms is determined from 
the sum of fluorine and hydrogen atoms minus the total num-
ber of atoms capable of attaching to the carbon atoms 
present. 
6. Compouncls which are isomers possess the same 
propellant number, but are distinguished by symmetry .. 
The most symmetrical isomer uses the number alone, whereas 
letters a, b, c, etc., are added to isomers of decreasing 
symmetry. 
7.. Cyclic compounds are identified by the capital 
letter, c, before the number. 
8. If compounds are unsaturated, a fourth digit, 
{}----------1 the number one (1), is placed before the characteristic 
three-digit configuration (11). 
O.f these propellants, Propellant 12 and Propellant 
114 as a blend are the most widely employed for aerosol 
foam systems (11,20-23). Propellant 12 is hydrolyticall;y 
stable to most acidic and alkaline conditions and thus 
13 
permits use in aqueous products. It is odorless and has a 
low toxicity order. The vapor pressure of Propellant 12 is 
70.2 psig.a at 70°F. (11). Propellant 114 is highly stable 
to hydrolysis and also possesses a low toxicity ordere For 
these reasons, it is used for aerosol cosmetics and pharma-
ceuticals. The resultant vapor pressure of a blend of 
these two propellants in a weight-weight ratio of Propellant 
12 - Propellant 114 (40:60) as calculated by Sanders (11) 
is 35.6 psig. at 70°F. This ratio is commonly used when 
pressurizing metal containers. The chemical inertness and 
low orders of toxicity of the two propellants in this blend 
a - Pounds per square inch gauge. 
make them useful as propellants for topical aerosols., 
Herzka (23) has stated in reference'to Propellants 12, 
.114, and C-318 that "no skin sensitization by these pro-
pellants has been noted." "There have been no instances 
of any toxic effects resulting from the application of 
aerosol products to the skin where the effect could be 
attributed to the propellant," stated Reed (19).. As 
reported by Porush (18) "toxicity of the propellant is 
14 
not a serious problem for topical preparations where no 
:internal application is anticipated, because the propellant 
is usually evaporated from the solution before it even 
touches the skino '' 
lf.. The Product Syst.em 
There are three product systems capable of pro-
ducing aerosol foams. These are: aqueous emulsions, 
aqueous alcohol systems, and non-aqueous systems (11). A 
great number of medicaments with varying properties are 
capable of_ being incorporated into these product systemso 
Thus, flexibility is offered to the aerosol foam product 
designer. 
The aqueous emulsion system consists of water, 
propellant, and a suitable surface-active agent. Both 
oil-in-water and water-in-oil systems can be formulated. 
In the consideration of aerosol emulsions, the liquefied 
propellant is termed the oil phase (11). Therefore, for 
oil-in-water systems, the propellant is dispersed in an 
aqueous media and for a water-in-oil system, the water 
Lc___~--~-
phase is dispersed throughout a continuous media of 
liquefied propellant. The surfactants used in these 
product systems can be anionic, cationic, or nonionic 
and are either v.rater soluble or water dispersible. The 
propellants generally used are the fluorocarbons (11). 
The water-in-oil emulsions have a continuous 
phase of propellant only, or a mixture of propellant, 
solvents, and other active constituents.. These 'l.vater-in-
15 
oil emulsions usually produce non-foaming systems .. Because 
of the high propellant ratios, sprays are produced which 
consist of aqueous droplets.. Products using the vTater-in--
oil emulsion system include: room deodorizers, insecti-
cides, hair sprays, moth proofers, and furniture polishes 
(11). 
The aqueous emulsion product system, v1hich accounts 
for the majority of marketed foam products is the oil-in-
water system. \'later and water soluble ingredients provide· 
the continuous phase in these emulsions. Both sprayable 
foams and conventional foams can be produced from these 
oil-in-water emulsions. The sprayable foams contain a 
_ lower concentration of surfactant than do the conventional 
foams which generally employ a four percent by weight 
concentration. Sprayable foams are not generally used 
medicinally but are used for window, oven, or bathtub 
cleaners and for spray starch. The conventional foam is 
used for both cosmetic and pharmaceutical products, vrhich 
are hydrolytically stable. Products included here are: 
16 
shaving creams, hand creams, shampoos, hand disinfectants, 
and others (11). The surface-active agents used in these 
products are anionic and nonionic, with limited use for 
the cationic agents. For cosmetic and pharmaceutical 
foams, the nonionic surfactants are more widely used, 
since these surfactants possess minimal skin irritation 
propertiese Pharmaceutical foams can be produced from 
these oil-in-water aqueous emulsion systems with clue regard. 
---------- ----- ------- ----------------
for the hydrolytic compatibility of incorporatecl medica-
ments. For most commonly employed topical antibiotics, 
these aqueous systems prove unfeasible. 
The second product system capable of producing 
foams is the aqueous alcohol system~ These systems are 
unique, since either emulsified or non-emulsified products 
can be formulated. The components used in formulation 
include water, ethyl alcohol, surfactant, and propellant. 
The surfactants used are of the same type as employed in 
the aqueous system. Some commercial, aqueous alcohol foam 
products include: insect repellents, skin moisturizers, 
sunscreens, athletes· foot remedies, and after-shave: 
preparations. 'The aqueous alcohol emulsified system is 
similar to the aqueous emulsion system in its' properties. 
But, because of the alcohol content, the emulsion is 
generally less viscous and produces foams which are less 
stable, thermodynamically. The non-emulsified aqueous 
alcohol system possesses a unique property. It is a clear 
system with all constituents: water, alcohol, surfactant, 
1? 
and propellant being miscible, but yet it produces a foam 
product. This eliminates the need for shaking of the 
product prior to dispensing - a definite advantage. This 
phenomenon of mutual miscibility is concentration dependent 
' ' 
within specific limits~ Both surfactant and propellant 
ratios are critical and any factor which alters these 
ratios can cause the system to revert to an emulsified 
state. Because of this factor, foam production from a 
clear system is possible, since upon discharge the pro-
pellant volatilizes causing the once solubilized surfactant 
to precipitate from solution and stabilize the foam. This 
stabilization is termed solid stabilization by the sur-
factant. Because of the alcohol content in either the 
emulsified or non-emulsified system, the foams produced 
are less stable than a foam from a comparable aqueous sys-
tem. This limited stability of the resultant foam products 
has created a relatively new foam type, the quick-break 
foam (24). These foams readily collapse after discharge 
producing a liquid. , The aqueous alcohol quick-break foams 
·have found their major application for cosmetic products, 
althoug!J, pharmaceutical quick-break foams could be quite 
advantageous for some medicaments. As with the aqueous 
systems, medicinals incorporated into the aqueous alcohol 
systems must be completely compatible 'IIlith system ingredi-
ents.· Hence, these aqueous alcohol systems could not be 
used as vehicles for the commonly employed topical anti-
biotics, again because of their water content. 
The non-aqueous system is the third product system 
capable of foam production. There are two types of non-
aqueous systems: the glycol emulsion and the mineral oil 
system. Sanders (11) has stated that there is relatively 
little information published on the non-aqueous systems 
and that there are essentially no aerosol products on the 
market which use this type of system. r1uch information 
has been reported through the work of Sanders on both non-
18 
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aqueous and aqueous alcohol aerosol systems (11,20,21,22). 
Sanders (11) has further stated that the non-aqueous systems 
have not been used appreciably, since they are relatively 
new, but that they offer a number of advantages especially 
for many applications in the cosmetic and pharmaceutical 
f:i,.elds. "The non-aqueous foam systems are particularly 
useful for active ingredients that are sensitive ·tio mois-
ture11 (11). Commonly used topical antibiotics might \oTell 
be adapted to incorporation into such systems. 
The mineral oil system consists of mineral oil, 
surface-active agent, and propellant. Sanders (11,22) has 
found the ethoxylated fatty alcohols or miJrtures of cetyl 
and stearyl alcohol to be the most useful surfactants for 
mineral oil foams. Propellant 12 gave adequate foams, 
whereas Propellant 12/114 (40:60) gave good foams. These 
propellants are generally soluble in the mineral oil base, 
but the surfactants must be insoluble. Should the sur-
factant be solubilized by the propellant a clear, homogenous 
product system is possible, demonstrating the same foam 
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formation properties and advantages of the non-emulsified 
aqueous alcohol foam system. If the surfactant is not 
solubilized by the propellant, then it is dispersed 
throughout the propellant-mineral oil solution (11). The 
disadvantage of a product formulated with the mineral oil 
system is that it provides a greasy and non-vmshable baseo 
~~his factor might vmll be advantageous for a suntan foam 
product. other topical foam products of cosmetic or pharma-
ceutical importance which might utilize this system include: 
baby oils, hormone creams, and vitamin creams (11) .. 
The glycol emulsion system consists of a glycol or 
glycol derivative, propellant, and suitable surfactant .. 
As the name of the system implies, the propellant is usually 
emulsified in the glycol media. The surfactant is also 
insoluble and exists as a suspended solid. Sanders (11,22) 
has stated that "in a fe"V-r instances, the propellant may be 
soluble in the glycol concentrate, and in some formulations 
the surfactant may be soluble in the glycol-propellant 
mixture, but in all cases the surfactant is insoluble in the 
glycol concentrate." The types of glycols available are 
many, but the choice should be limited by topical toxicity 
considerations. Sanders (11) has also reported that, as 
based on his findings, propylene glycol, 1,3-butylene glycol, 
and the polyethylene,glycols are relatively low in toxicity 
and give stable foams. Glycerin, although of low toxicity, 
produces extremely viscous product systems and is not as 
satisfactory by itself as other glycols for non-aqueous 
foams., 1I'he low molecular weight polyethylene glycols, 
propylene glycol, and 1,3-butylene glycol do not produce 
such viscous emulsions (11). Surfactants found useful in 
the production of the aqueous alcohol foam system are also 
useful in the non-aqueous glycol system. As demonstrated 
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by Sanders (11,22), ethoxylated fatty alcohols and pro-
pylene glycol monostearate (self-emulsifying) are espe-
cially useful for stable glycol foam production. Propel-
lants producing excellent glycol foams are blends of 
Propellant 12 and 114 (11,22). These glycol foams, formu-
lated from the above mentioned substances, are generally 
very stable. By the addition of ethyl alcohol to the 
formulationSa:nders (11) reports an increase of foam 
pressure sensitivity. Thus, foam stability is reduced 
and liquefaction increased. This phenomenm1might well be 
considered for the production of quick-break and inter~­
mediate glycol foam products. The possible advantage of 
such products would be a faster diffusion rate of incor-
porated medicament from the foam vehicle to the application 
site. Of all the foam producing systems available, the non-
aqueous glycol foam system offers the most advantages for 
the incorporation of hydrolysis sensitive topical anti-
biotics. 
The Theory of Foam Formation 
It is the emulsion which forms the basic system 
:for the formation of most aerosol foams. In all of the 
product systems considered above, the emulsion principle 
is used in each. In most of the aerosol foam products, 
the emulsions are of the oil-in-vvater type despite the 
surfactant chosen, because the amount of emulsified pro-
pellant is generally 10 percent or less. Thus, the pro-
pellant is emulsified as a droplet surrounded by the 
continuous phase chosen in the formulation. 
These emulsions are thermodynamically unstable, 
undergoing the phenomena of propellant droplet floccula-
tion, creaming, and coalescence. This results in complete 
phase separation of the dispersed propellant and the con-
21 
tinuous phase.. In all bf these emulsion systems, the 
surface-active agent, i.vhich is dispersed or solubilized 
throughout the continuous phase, retards the emulsion 
bree.kdo-vm. A surfactant, by definition, functions at the 
interfacial region. For aerosol emulsions, this interface 
is the propellant droplet-continuous phase boundary. Thus, 
the surfactant acts as a stabilizer retarding emulsion 
breakdO\m ( 11) • 
Two major theories have been advanced \•rhich account 
.for emulsion stabilization. The· first theory is based on 
electrical charge. The dispersed droplets o.f propellant 
possess electrical charges around their boundaries which 
provide for mutual repulsion of the dispersed droplets. 
The electrical charge occurring at the interfaces results 
.from the charge on the propellant droplets themselves as 
well a~ from orientation of ionized surface-active agent. 
Thus, electric double layers can exist at the interfaces. 
Should London-van der Waals forces of attraction exceed 
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the electrostatic repulsive forces of the electric double 
layer surrounding the emulsified propellant droplets, then 
emulsion .flocculation would ensue. This theory o.f electric 
charge stabilization applies primarily to emulsions stabi-
lized with anionic or cationic surfactants.. It should be 
noted that emulsion coalescence is not accounted for by 
---------- ---------- --------- ---r---- - the above theory' since coalescence is dependent upon dis-
ruption of surfactant produced interfacial film (ll)e 
The second theory is directly related to the inter-
facial film produced by a surfactant which surrounds the 
propellant droplets. This surfactant film prevents droplet 
coalescence. The nature of this .film has been attributed 
to molecular complex .formation between surfactants and 
long-chain compounds., vlliere molecular complex formation 
is not possible, the nature of the film can be attributed 
to solid stabilization. This is stabilization by minute 
insoluble particles o.f surfactant. Anionic, cationic, and 
especially nonionic surfactants can stabilize emulsions by 
this interfacial film theory. Further stabilization is 
made possible by hydration of the films by solvent result-
ing from ion-dipole interaction and hydrogen bonding (11). 
The aerosol emulsion system upon discharge, pro-
duces a foam which is a coarse dispersion of vaporized 
propellant in a liquid matrix. The foam, like the emulsion, 




as a result of several factors. Drainage of the liquid 
occurs from capillary actio~ and gravitational force. 
Capillary attraction is strongest in the regions called 
Plateau's borders - junctions bet\·Teen three vaporized 
propellant bubbles. In these regions, drainage is largely 
a surface tension phenomenon. As drainage progresses, the 
liquid films, or lamellae, separating entrapped propellant 
bubbles, thin and rupture, allowing bubble coalescence and 
foam collapse (11). The presence of the surfactant in the 
foam formula, as in the emulsion system, retards this 
degradation process. 
The stabilization of aerosol emulsions and foams 
has been elucidated largely through the \'lOrk of Sanders 
(11,25,26,27).. The theory of stabilization of emulsions 
in many aspects is the same theory which governs stabili-
zation .of foams. 'sanders (11) has stated that electrical 
repulsion is a minor factor in foam stabilization, but 
that the theory of three-phase solid stabilization (25) 
can and does explain foam stabilization of all three product 
systems: the aqueous emulsion, the aqueous alcohol system, 
and the non-aqueous system. According to Sanders (25),. 
Bikerman has referred to foams stabilized by solids as 
three-phase foams. 
To account for this solid stabilization, Sanders 
(25) acknov1ledges the liquid crystal theory of La-v~rence 
that is referred to by Alexander (28). According to this 
Lawrence-Alexander theory a liquid crystal structure exists 
at interfacial regions consisting of ionized surfactant 
and fatty alcohol complex in a layered molecular structure 
similar to that of solid inorganic stabilizers. Sanders 
(27) has sho\m that molecular complexes of polyoxyethylene 
fatty ether - fatty alcohol or acid are liquid crystals., 
As stated by Rosevear (29) liquid crystals are mesomorphic 
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structures intermediate bet\veen liquids and solids.. JPor 
aqueous systems, hydration layers can separate the alternat-
---- ------- - -- --- - -- - -- - - ---- -- --
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ing layers of surfactant in the liquid crystal. All three 
types of.surfactants: anionic, cationic, and nonionic can 
form mesomorphic phases or liquid crystal molecular com-
plexes (25,27). Aqueous, aqueous alcohol, and non-aqu·eous 
aerosol foam systems are stabilized through the mechanism 
of solid stabiJ.izationas Sanders' (25) data demonstrates. 
But the data obtained by Sanders (25) suggests "that it is 
not a molecular complex necessarily that is needed to obtain 
a stable aerosol foam but only a solid surfactant with the 
right wettability properties." The term three-phase solid 
stabilized foams has been used to describe these systems. 
This description is applicable, since vaporized propellant 
(gas), entrapped s.olvent (liquid), and surfactant as a 
solid or liquid crystal (solid) are present in the foam 
matrix. Figure 2 demonstrates this concept. Thus, as the 
aerosol product is discharged, a foam is produced by the 
action of vaporizing propellant, whipping the emulsion or 
non-emulsified clear system into a foam. In the emulsion 
system, solid surfactant is present to stabilize the foam. 
FIGURE 2. 
DIAGRAMATIC REPRESENTATION OF THE SOLID STABILIZATION THEORY 
OF FOAM FORMATION: 
VAPORIZED ~--~-SOLVENT 
·6 ·.o:¢: PROPELLANT 











In the non-emulsified clear system the surfactant 
· precipitates from a previous solubilizing media as a 
result of propellant loss via vaporization. Then, the 
surfactant is able to solid stabilize the foam. 
Sanders (25) has further stated that the stability 
of foams, produced from all three product systems, "is 
directly related to the solubility of the surfactant in 
the concentrate." Thus, surfactant solubility screening 
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in a series of solvents, would prove to be a useful pro-
cedure for the prediction of aerosol foam formation. From 
this screening, effective surfactants and solvents would 
be identified .. 
~he ~}}.QS? .. Y. of li'oam Formulation 
As based upon the solid stabilization theory and 
surfactant insolubility criteria advanced and supported 
by Sanders (25,), aerosol foam systems may readily be formu-
lated. 
In most aerosol foam formulas, a low propellant to 
concentrate ratio is used. A general formula for aerosol 
foams is: Solvent 80 90% w/w 
Surfactant 0.5 - 5% 
Propellant 6 - 10% (11) 
This formula can be adapted to the aqueous, the aqueous 
alcohol,.and the non-aqueous product systems. Thus, it 
would be possible to produce many foams with prolonged 
stability. Once stable foams have been produced, 
intermediate and quick-breaking foams can be formulated 
by the addition of a suitable cosolvent in which the 
surfactant is soluble. 
The propellants generally used in the three foam 
systems are the fluorocarbons (11). It is the choice of 
the surfactant which is the critical consideration for 
the type of foam system to be produced. Thus~ the theory 
of foam formulation is dictated by the theory of foam 
---- ----------- -------- --------- -------- ---- --- -------- --- --- -- ----
formation. It is the three-phase solid stabilization 
principle which determines foam production (11,25). 
'l'he therapeutic active ingredient to be incor-
porated into a foam producing system, largely determines 
which aerosol foam system is to be used~ The system 
chosen must provide proper stability for the incorporated 
medicament and must also produce a foam with desirable 
properties for the use intended. The non-aqueous glycol 
system e~empli.fies the product system of choice for effec-
tive topical antibiotics. 
Once a product system has been determined, it is 
then possible to screen a random or selective series of 
surface--active agents for their solubility properties in 
the solvent of the chosen product system. Those sur-
factants which are insoluble in the solvent may then pro-
duce solid stabilized foams (25). Foam production can 
then be tested by actual formulation of the foam vehicle 
(without active constituents) or the foam product (with 
active ingredients). If stable foams result, intermediate 
2? 
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and quick-break foams may also be produced. 
Ternary solubility studies, using triangular 
coordinate graphing, for surfactant, solvent, and cosolvent 
can elucidate useful aerosol formulas for intermediate and 
quick-break foam production~ The process consists of 
selection of a suitable cosolvent. The cosolvent should 
be miscible \'lith the solvent and should render the sur-
factant soluble.. Thus, titration of the surfactant \vith 
the solvent will cause a cloud point, i.e .. , precipitation 
of surfactant, and addition of cosolvent \'Jill cause resolu-
bilization.. From this repeated process, a series of points 
on a triangular coordinate scale will define a surfactant 
solubility curve. From this curve, the formulator may 
choose appropriate surfactant, solvent, cosolvent ratios, 
which when tested, may produce intermediate or quick-
breaking foams. 
Advantages o~ ~he Aeroso~ Foam 
Inherent advantages (10,23,30) of dermatological 
pharmaceutical aerosols have been outlined: 
1. fast, convenient, and efficient application 
method; 
2. elimination of waste or messiness in the 
application process; 
3. elimination of product contamination from 
oxygen, moisture,. or micro-organisms, since 
the container is hermetically sealed; 
4. protection of medicaments destroyed by air 
moisture hydrolysis; 
5. reduced or eliminated irritation to already 
traumatized or infected sites by exogenous 
mechanical, chemical, or bacterial vectors; 
6.. application of either thin or thick layers 
to the affected areas; 
7. application of medicaments o:f very small 
particle size, which \'!Ould reduce irrita-
tion and enhance dermal penetration. 
Other advantages to be realized by use of a topi-
cal aerosol foam product include: 
1. application of the product to a large or 
-----~-------sma-Ja--1.--- -area--vJi~C-h equa-l-- ease;-- ---- -- --- - - -----
2. the soothing emolliency characteristic of 
a cream or ointment, produced by the break-
dmvn of a :foam formulated as an emulsion 
system; 
3. the better penetration of medicinals incor-
porated into the aerosol foam afforded by 
the foams ability to debride skin lesions 
and spread. 
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The ability of a formulator to incorporate a 
dermatolpgical medicinal agent into a foam vehicle is 
readily realized by reviewing the three product systems 
capable of producing foams. Ingredients can be solubilized 
or dispersed in product systems using vehicles of water, 
alcohol and water, glycols, or oils. These systems would 
accommodate active constituents of varying physical and 
stability properties. Thus, from the product formulators 
viewpoint, the aerosol foam systems would be a functional 
and flexible topical dosage form. 
Because foams of varying stability can be formu-
lated, other advantages would be inherent. A stable foam 
product vTould possess the ability to retain medicament at 
the site of application and provide for a more prolonged 
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release of the incorporated active ingredient. A foam of 
intermediate stability would retain and yet release medica-
ment at the application site at a faster rate. Cooper (24) 
has listed several advantages of a quick-·break foam. For 
dermatological considerations, the quick-break foam \vould 
provide for immediate release of incorporated drug, enabling 
immediate availability of medicament to the affected site .. 
Thus, the aerosol foam vehicle could provide varying release 
------- ----
----rateS-for-incorporated medicaments. 
As stated by Porush (18), "there is only one dominat-
ing reason for packaging a pharmaceutical in a pressurized 
container, and that is to produce a result that cannot be 
achieved. by conventional means .. " Kanig (2) in reference to 
pharmaceutical aerosols has stated that "unless they offer 
advantages not novr possible with existing dosage forms, 
pressurized drugs \llill not be sustained on the basis of 
consumer convenience alone." By review of the advantages 
ot the aerosol foam, as stated above and from the patient 
need experienced in.hospital pharmacy, it is the author's 
belief that a topical antibiotic-containing aerosol foam 
would meet the criteria of Porush and Kanig and effectively 
supplement the therapeutic topical dermatologic products. 
Objectives 
It is the major objective of this study to formu-
late suitable aerosol foam vehicles, which would prove 
useful for topical antibiotic incorporation and to physically 
screen these .formulations for ideal foam properties. 
Therefore, the objectives of this endeavor are: 
1. to screen an arbitrary series of surface-
active agents for their solubility in a 
.series of solvents including: Alcohol 
U.S.P., Isopropyl Nyristate, Purified 
Water U.S .. P. , Polyethylene Glycol 1+00 
U.S.P., and Propylene Glycol U.S.P.; 
2. to attempt to formulate stable aerosol 
foruns on the basis of the solubility 
stud.ies; 
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foams \'lith appropriate solvents and 
cosolvents to establish triple coordinate 
solubility graphs; 
'+., to attempt to formulate intermediate and 
quick-break foams from formulas based on 
the triple coordinate solubility studies; 
5. to incorporate Neomycin Sulfate U.S.P., 
Polymyxin B Sulfate U.S.P .. , Gramicidin 
N.,lt,,., and Zinc Bacitracin u.s.P. into 
the stable, intermediate, and quick-
break foam vehicles obtained; 
6. to evaluate physical and stability prop-
erties of these potential antibiotic 
aerosol foam products. 
EXPERIMENTAIJ 
General Surfactant Solubili_t~~ing 
Solubility screening of an a.rbi trary series of 
surfactants in different solvents provides valuable informa-
tion for the production of aerosol foamso Sanders (25) has 
stated that the stability of .t'oams ~'is_ directlY related to __ _ 
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the solubility of surfactant in the concentrate .. " The 
insolubility of a surfactant in a _solvent becomes a major 
criterion for foam production by the three-phase solid 
stabilization theorye Thus, surfactant screening in a 
sol vent proves to be a useful tool for the foam formulatore 
Although a surfactant may be insoluble in a given solvent, 
no foam may be produced from a proposed formulation. This 
possibility exists because the propellant may exert some 
solubilizing effect on the surfactant or because of some 
other factor. Hence, surfactant solubility screening is 
a useful preliminary means for the prediction of possible 
foam production, but not the determinate means for foam 
realization. 
The solvents chosen for this project included: 
Alcohol U.S.P., Isopropyl Myristate, Purified Vlater U.S.P., 
Propylene Glycol U.S.P., and Polyethylene Glycol 400 U.S.P. 
Polyethylene Glycol 400 is a chemical polymer of 
ethylene oxide and water. Its formula is presented chemi-
cally as H(OCH2cH2 )nOH, vrhere the average n varies from 
8.2 to 9.1~ It is a clear, colorless, viscous liquid, 
which is slightly hygroscopic and possesses a specific 
gravity of 1.110 to lelL~O. It is miscible with water, 
alcohol, and other glycols. The blandness of this chemi-
cal has made it useful for hair dressings, hand lotions, 
sun--tan creams, leg lotions, shaving creams, and skin 
creams.. Polyethylene Glycol L~OO has been used extensively 
in washable ointment bases (31). It possesses excellent 
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emollient properties. The polyethylene glycols have been 
reported by Sanders (11) to be excellent vehicles for 
stable glycol foams of low toxicity. This compound is 
also a useful solvent for hydrolysis sensitive topical 
antibiotics .. 
Propylene Glycol is another useful vehicle for 
antibiotic foams. It has also been described by Sanders 
(11) as being capable of producing stable glycol foams. 
Chemica-lly, it is 1,2-propanediol. It is a clear, color-
less, slightly hygroscopic, viscous liquid with a specific 
gravity of 1.035 to 1.037. It is miscible with water and 
ethanol (32). It has been used as a medicinal solvent and 
as an aerosol antiseptic (33). Propylene Glycol also 
possesses emollient properties. 
Isopropyl Myristate possesses excellent emollient 
( 
and lubricant properties, 'VJhich make it useful for topical 
application. It has been used extensively as a vehicle in 
pre-electric shave formulas. The specific gravity of this 
compound was determined using a hydrometer and was found 
to be 0.85. It has not been used as a vehicle in any foam 
formulas. This chemical might also be useful as a cosolvent 
for intermediate or quick-break foam formation. 
Purified Water has been included in the initial 
surfactant screening to serve as a supplementary guide for 
aqueous or aqueous alcohol foam production. Although it 
is not to be used in an·f;ibiotic foam formulation, it is 
included in this project to supplement the solubility data 
available on the surfactants analyzed. 
Alcohol U.S.P~ is a volatile liquid with a specific 
gravity not above 0.816 at 15.56°0~ It is used extensively 
in pharmacy for its solvent properties and eJ\.rternally it is 
an excellent antiseptic. Because of its solvent properties,· 
it could .. read.il.y function as a cosolvent in intermediate 
and quick-break foam formulas (34-) •. 
The surface-active agents used in this project 
represent a random arbitrary series available from various 
manufacturers. The surfactants have not been identified 
chemically so that bias would be minimized. The surfactants 
will be identified chemically when the final foams have been 
produced. 
The procedure used in this general surfactant solu-
bility screening consisted of placing 500 mg. of surfactant 
in 10 ml. of solvent. The container with the surfactant 
and solvent was covered and was heated to 50°0 on a water 
bath with agitation. The system \'Tas then allowed to cool 
to room temperature. The data obtained are recorded in 
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Table 1. Surfactant solubility is indicated as: completely 
soluble (++++), soluble (+++), slightly soluble (++), very 
slightly soluble (+), and insoluble (-). 
Surfactants with the potential of producing stable 
foams are listed in Table 2.· These surfactants showed 
complete insolubility in the specific solvent indicated. 
Evaluati_op_ .of ProP«.sed Stable J!'oam :B'ormulas 
____________ -~he re_a.li_zatiQn of foam _production is ultimately 
accomplished through the testing of the proposed formula-
tion. The surfactants and corresponding solvents listed 
in Table 2 were tested for production of stable foams .. 
Stable foam production from these insoluble surface-active 
agents is based on the three-phase solid stabilization 
theory (25). 
As found in the literature (11,22,23,25), the most 
frequently used formula for non-aqueous stable foam pro-
duction is: Solvent 86% w/w 
Surfactant 4% 
Propellant 12/114(40:60) 10% 
This basic formula has_been adopted in the formulation of 
stable foams for this research project .. 
In Table 3, the results of the foam formulations 
have been summarized. Also included in this table are: 
system appearance, foam production, foam stability, valve 
release, and pH number. 
The appearance of the foam system provides valuable 
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TABLE 1 
GENERAL SURFACTANT SOLUBILITY SCREENING 
SURFACTANT SOLVENTS 
A. a \v. o ~ M c ..L .. l., P.G. d P.E.G • e 
CRODA INC.1 
Polawax A22 ++++ - ++++ 
Lot 102866 
Polawa..x A31 ++++ - ++++ 
Lot 183A 
Satexlan 20 ++++ ++ - - -
Lot B-2 
Volpo 3 ++++ - ++++ ++++ ++++ 
Lot 617 
Volpo 10 +++ - ++ ! ++++ ++++ 
Lot 792 
Volpo 20 ++++ +++ - -, ++++ ++++ 
Lot 834 
Crodafos N 3 Neutral ++++ ++ ++++ ++++ ++ 
Lot 912 
Crodafos N 10 Acid ++++ ++ ++++ ! +++ ++++ \.),! (J, 
Lot 1210 
·- --· ···~·~--------
TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
A. a 1:1. b r.r1 • c P.G. d P.E.G .. e 
. Crodafos N 10 Neutral ++++ ++++ ++++ ++++ +++ 
Lot 1020 
Crodafos N 3 Acid ++++ - ++++ +++ + 
Lot 1124 
Crodafos CAP ++++ - ++++ +++ 
Lot 1 
Polychol 5 ++f f ++ ++++:f + -
Lot 148 
Po1ychol 10 ++++f ++f ++ ++++:f ++++ 
Lot 202 
Polychol 15 ++++f + f ++ ++++f ++++ 
Lot 3018 




+· ++++ :f ++++:f ++ + 
Lot 516 
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TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
A. a \·J.b I .. r-1. c PeG. d P .. E .. G .. e 
F1ui1anol - - ++++ 
Lot 3670 
Afv1ERICAN 
CHOLESTEROL 2 PRODUCTS INC. 
Amercho1 BL - - ++++ Lot 135F 
Amerchol·C - - ++++ 
Lot 224F 
Amerchol H9 - - ++ 
Lot 206F 
Amerchol L-101 ++f' f' - ++++ -f' ++++ 
Lot 614F 
Amerlate LFA - - +++ - + 
Lot 20F 
Solulan 5 ++++ - ++++ ++ 
Lot 103F 
Solulan 16 ++++f' ++++f' i ++++f ++++ ++++ 
Lot 83F \).1 co 
.. -~ . 
TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
a fr c- -- ---~- . ----a: e 
A. - v:1. r.r1.. , P .. G. P.E.G • 
. So1u1an 25 ++++ ++++ - ++++ +++ 
Lot 110F 
So1u1an 97 ++++ ++++ ++ 1 + ++++ 
Lot 49F 
Solu1an 98 ++++ ++++ ++ : + ++++ 
Lot 125F 






Bri j 72 ++++ - ++++ 
Batch 450513 
G-1441 ++++ ++++ ++ i ++++ ++++ 
Batch 8723A 
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TABLE 1 (CONTINUED) 
SURFACTAI'l'T SOLVENTS 
A. a \·1. I .. rvr .. c P.G. 
-d 
P.E.G. e 
Tween 60 ++++ ++++ ++ ++ ++++ 
Lot 854 






Emerest 238lg - - + 
Emsorb 2515g ++++ - ++++ i ++ ++++ 
Ernsorb 2500g ++++ - ++++ I+ ++ 
Emsorb 2510g + 
Emsorb 2505g 
Emsorb 2503g - - ++++ - + 
Emsorb 2507g - - ++ 
-t:: 
0 
I'll' -·-- ----~ 
TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
~-· -··- -------
A. a \'! .. b T 1\1 e d e -·"' . P .. G. P.E .. G. 
MIRANOL CrlliMICAL 
·cOMPANY, INC.5 
Miranol CM Cone. ++++ ++++ - I ++++ + 
Lot 7645M70 
Miranol C2N Cone. ++ ++++ + ++++ + 
Lot 7675M70 
Miranol HM Cone. ++++ ++++ - ++++ ++ 
Lot 7407M69 
Miranol H2M Cone. ++++ ++++ - i ++++ ++ 
Lot 7453r-169 
Miranol JEM Cone. ++++ - - ++++ ++++ 
Lot 7627f170ST 
Miranol L2M-SF Cone. ++++ ++++ - ++++ 
Lot 7595!>169 
Miranol 2MCA ++++ ++++ - I++++ +++ 
Hodified 
Lot 7667IvJ.70ST 
Miranol SM Cone. ++++ ++++ - I++++ +++ 
Lot 7 562!>169 -+=:-
f-' 
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TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
-·--· d A. a w .. b I.fJI.e e P .. G .. P.E.G • 
. I-liranol S2M Cone. ++ ++++ - ++++ ++ 
Lot 543 51'-166 




Aromox C/12 ++++ ++++ + ++++ +++ 
Lot 9286 




Aromox Dr1ICD ++++ ++++ ++ I ++++ ++++ 
Lot 9703 
Aromox DMCDW ++++ ++++ + ++++ ++++ 
Lot 1007-7 
Aromox DNHCD\'1 ++++ ++++ + i ++++ ++++ 
Lot 1007-4-























,,,, =I - I 
TABLE 1 ( CONTThUED) 
SOLVENTS 
--------;---- a -- ---b 








'I• I• - -~ 
TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
a A •. 1JJ e I .. r-T .. c P .. G .. d P .. E.G.e 
Tegamine C-13 ++++ ++++ ++++ ++++ +++ 
Lot 8209 
Tegamine L-13 ++++ ++ ++++ ++++ ++++ 
Lot P480 
Tegamine 0-13 ++++ - ++++ ! ++++ ++++ 
Lot 589 
Tegamine P-13 ++++ - ++++ ' ++++ i 
Lot P546 
Tegamine S-13 ++++ 
Lot P440 
Tegamine 22 ++++ - ++++ 
Lot P618 
Tegarnine IS-13 ++++ - ++++ ++++ ++++ 
Lot P452 
Tegobetairte C ++++ ++++ - ! ++++ ++++ 
Lot P632 
t 
TABLE 1 (CONTINUED) 
SURFACTANT SOLVENTS 
-- ~---~------- -- ~L--
b ·a I.,.M.c I P .. G:cr P.E.G.e A. vl. 
I 
. STEP AN gHENICAL 
COI1PANY 
Amidox C-5 ++++ ++++ - I ++++ ++++ 
Lot 9-31690 
Amidox L-5 ++++ ++++ - I ++++ ++++ 
Lot 9-21516 
Nino1 AA-62 ++++ ++++ - I ++++ ++++ 
Lot 9-31037 
Nino1 AA~62 Extra ++++ +++ ..l... . -,- ++++. ++++ 
Lot 9-32066 
Nino1 128 Extra ++++ - - ++++ ++++ 
Lot 23273 
Nino1 201 ++++ - ++++ ++++ ++++ 
Lot 9-21322 
Nino1 2012 Extra ++++ +++ +++ ++++ ++++ 
Lot 40104 




TABLE 1 (CONTINUED) 
TABLE 1 (CONTINUED) 
SURF ACTA...WT SOLVENTS 
-~----~ 
A'. a "' \'l. lJ I.N .. 0 P.G. a P.E.G. e 
Stepanol \vAQ ++ ++++ - ++ ++ 
Lot 30793 
Stepanol vlAT ++++ ++++ - I ++++ ++++ 
Lot 39077 
B. F. GOODRICH · 
CHEf-UCAL COMPANY9 
Carboset 514g ++++ ++++ - +++ ++++ 
30% Total Solids 
Carboset 515 ++++ - - 1- ++++ 
Lot G-1871 
Carboset 525 ++ - - I + ++ 
Lot 25085 
SANDOZ CHEMICALS10 




Emcol 14 - - ++++ 
I -
+ 
Lot 492 -+=" ......:1 
'-"'-~-~-- ~ 
TABLE 1 (CONTIWUED) 
1- Croda Inc., New York, N. Y. 
2 -American Cholesterol Products Inc., Edison, N. J. 
3 - Atlas Chemical Industries, Inc., Chemical Division, Wilminjston, Del. 
I 
4- Emery Industries, Inc., Los Angeles, Ca. 
5- Miranol Chemical Company, Inc., Irvington, N. J. 
6 - Armour Industrial Chemical Company, Chicago, Ill. 
7 -Goldschmidt Chemical Corp., New York, N. Y. 
8 - Stepan Chemical Company, Northfield, Ill. 
9 - B. F. Goodrich Chemical Company, Cleveland, Ohio5 
10 - Sandoz Chemicals, Hanover, N. J. 
11- Witco Chemical Corp., New York, N. Y. 
a - Alcohol U.S.P. 
b - Purified Water U.S.P. 
c - Isopropyl Myristate. 
d - Propylene Glycol U.S.P. 
-!==' 
OJ 
e - Polyethylene Glycol 400 U.S.P. 
f- These values are from the solubility studies of Vollbrecht,jD. E., The 
Development of Aerosol Foams. Thesis, University of the Pa~~ific, 1967. 
g - Lot number not available. 
~ 
TABLE 2 
SURFACTANTS AND SOLVENTS 
CAPABLE OF STABLE FOAM PRODUCTION 
SURFACTANT SOLVENT(S) 
Po1awax A22 a P .. G. , P .. E.G. b 
Po-l-a-\1-a¥~1t~ 1 P .. -G-.. -;-:1?-.,-E.-G-. 
Sate:x:lan 20 P.G., P.,E.G., I.M. 
Vo1po 10 I.M. 
Vo1po 20 I.IVI. 
Crodafos CAP P.E.G. 
Fluilanol P.G., P.E .. G., A.d 
Amerchol BL P .. G .. , P .. E.G., A, 
Amerchol c P.G., P .. E .. G., A. 
Amerchol H-9 P.G., P.E.G. 
Amerchol L-101 P.G. 
Amer1ate LFA P.G., A. 
So1ulan 5- P.E.G. 
Solulan 25 I.M. 
\vaxolan P.G., P.E.G., A. 
Arlacel 60 P.G., P.E.G., A., 
Brij 72 P.G., P.R.G. 
Emerest 2400 P.G., P.E.G., A., 
Emerest 2407 P.G., P.E.G., A.' 







TABLE 2 (CONTINUED) 
.... 
SUR]'ACTANT SOLVENT(S) 
Em sorb 2510 P .. G .. , P.E.G., I .. M .. 
Ems orb 2505 P.G., P.E.G., A., I. ~1. 
Em sorb 2503 P.G., A .. 
Ems orb 2507 P.G .. , P .. E.G., A • 
.Miranol CN Cone. I.M .. 
Miranol HH Cone. I.M. 
Ml.ranol H2!'<1 Cone. I.M. 
M:iranol JE:f\1 Cone .. I.~1. 
JVI:iranol :L21'-1-SF I.M. 
Hiranol 2!VICA Modified I.M .. 
Miranol SM Cone. I.M. 
Miranol S2M Cone. I.M. 
Miranol SI-ID Cone. I.M. 
Tegin P.G., P.E.G., A., I.M. 
Tegin 515 P.G., P.E.G., A., I.M. 
Tegin 530 P.G., P.E.G., A., I.M. 
~egin 55-G P.G., P.E.G., A., I.M. 
Tegin P P.G., P.E.G., A. 
· Tegacid Regular P.G., P.E.G., A., I.M. 
Tegacid Special P.G., P.E.G., A., .I.M. 
Tegamine B-13 P.G., P.E.G., I.M. 
Tegamine P-13 P.E.G. 
Tegamine S-13 P.G., P.E.G., I.M. 















Stepanol WA Special 
St epanol V.l.AC 
Stepanol ~'lAQ 
Carboset 514 30% Total Solidse 
Emcol 14 
a - Propylene Glycol U.S.P. 
b - Polyethylene Glycol 400 U.S.P. 
c - Isopropyl Myristate 



















P.G., P.E.G., A. 




EVALUATION OF PROPOSED STABLE FOAM FORMULAISa 
----·-----
I 
SYSTEf1 FOAM FOAI~[ VALVE 
SURFACTANT APPEARANCE PRODUCTIONb STABIL]TYc - RELEASEd 
. '-~ : ii: i:· -~j·-=-·'' _...___ ______ _ 
S.¢BVm~T I • , . :_ PROPYLENE _ GLYGO:b U • S • P. . . ;;:. :.j; . ,,:c, l 
pH 
NUHBER 
,.,,/;.; .. ' . "1-
P~lawax A2.2 \fui t e + +24 'fij;:.· s. 
Cloudy :; : :· 
Polawa."'C A31 \fuite + +24 9·s. 
Cloudy . I 
Satexlan 20 White + 10 min. 
Cloudy , 
fl,: s~~·l!r7 






Amerchol BL \1hite 
Cloudy, S 
Amerchol C White 
Cloudy, S 
Amerchol H9 cf 
Amerchol LlOl Turbid 
3pg V1 
\.N 
TABLE 3 (CONTINUED) 
!_ 
SYSTEM FOAM FOAMb VAlVE d pH 
SURFACTANT ·APPEARANCE PRODUCTIONb STABILII yC RELEASE Nur1BER 
r 




Arlacel 60 vlhite 
Cloudy 
Brij 72 White 
Cloudy, Gh 
+ +24 hrs. ++ 8.0 
Emerest 2400 White + 15 mini. + 8.0 
Cloudy 
Emerest 2407 White + 15 mini. + 5.7 
Cloudy 
Emerest 2381 \vhite + +24 hr~,s. + 7-3 
Cloudy 
Emsorb 2510 White + 24 hrs!. - 6.65 
Cloudy, C 




TABLE 3 (CONTINUED) 
,! 
SYSTEM FOAM FOAM! VALVE pH 




Emsorb 2507 White + 30 mini. - 7.92 
Cloudy, C 
Tegin VJhite + 12 hrsl. + 6.15 
Cloudy, C. 
Tegin 515 White + 12 hrsl. - 7-5 
Cloudy, C 
Tegin 530 White + 1 hr.l + 7-4-5 
Cloudy 
Tegin.55-G White + 1 hr.l + 7.9 
Cloudy 
Tegin P · \nJhite + +24- hrs~ ++ 7.65 
Cloudy, C 
Tegacid Regular White + +24- hrs!•- . - 7.65 
Cloudy, C 





TABLE 3 (CONTINUED) 
!. 
SYSTEM POM1 POAMI V!:LVE d pH 
SURFACTANT APPEARANCE PRODUCTIONb STABILI1~yc RE.uEASE NUMBER 
Tegarnirie B-13 vlhite I 8.65 + +24 hr;3 .. ++ 
Cloudy 
Tegarnine S-13 Vlhite + 24 hrs!. ++ 8.4 
Cloudy 
Tegarnine 22 ~lhite +i 12 hrs.~ ++ 8.8 
Cloudy 
Erncol 14 Amber 
Cloudy 
SOLV:ENT II. POLYETHYLENE GLYCOL 400 U.S.P. 
Polawax A22 \llhite + I +24 hr;3. ++ 8.0 
Cloudy, G 
Pola-v1ax A31 White i 12 hrsl. 8.7 + ++ 
Cloudy, G 
Satexlan 20 vJhite 
Cloudy 
Crodafos CAP White 
Cloudy 
Fluilanol Amber 
Cloudy Vl (}) 
TABLE 3 (CONTINUED) 
.. -~ .. ·.·~· ·.· 
... 
SYSTEM FOA:tv1 FOAJr VALVE pH 
SURFACTANT APPEARANCE PRODUCTIONb STABIL1TYc RELEASEd l'ffirJIBER 
i 
Amerchol BL White 
Cloudy 
Amerchol C White 
Cloudy 
Amerchol H-9 White 
Cloudy, C 




Arlacel 60 White + +24 h:rj·s. - 8.0 
Cloudy 
Brij 72 \'lhite + +24 h:ds. + 8.0 
Cloudy, G, 
Emerest 2400 \'lhite + 1 hr. + 6.7 
Cloudy 









FOA~II SYSTEM li'OAM VALVEd pH 
SURFACTANT .APPEARA..l'ifCE PRODUCTIONb STABILI~ryc RELEASE NUI'·1BER 
I; 
. I 
I I I. Emerest 2381 White + +24 hrr ++ 8.3 
I • 
Cloudy 
Emsorb 2510 White 6.6 + +24 hrr -Cloudy 
Emsorb 2505 White 7.9 + +2lJ- hr~::. -
Cloudy 
Emsorb 2507 White + 20 minJ~ - 7.2 
Cloudy, C 
Tegin \'lhite +j 12 hrsJ, ++ 
Gloudy 
Tegin 515 White +i,j 12 hrsJ. + 
Cloudy 
Tegin 530 White +i,j 1 hr. I ++ 
Cloudy 
Tegin 55-G \llhite +j lJ- hrs .. 1 ++ 
Cloudy 




TABLE 3 (CONTINUED) 
I 
SYSTEM FOAH FOAI-1 'I VALVE pH 
SURFACTANT APPEARANCE PRODUCTIONb STABILI~~yc RELEASEd NUMBER 
I 
i 
Tegacid Regular White + i,j 3 hrs. 
Cloudy, C 
Tegacid Special '1.\Thite +j 1/2 hrs. 
Cloudy 




Tegamine P-13 White + ++ 7 .. 5 
Cloudy, G 
Tegamine S-13 White + 18 hrs.l ++ 7.9 
Cloudy, G 
Tegamine 22 White i 12 hrs.l 7.4 + ++ 
Cloudy 
Emcol 14 Amber 
·Turbid 
SOLVENT III. ISOPROPYL MYRISTATE 
Satexlan 20 Cloudy 




TABLE 3 (C01""TINUED) 
!. 
SYSTEM FOAivJ FOAIVII VALVE pH 
SURFACTANT APPEARANCE PRODUCTIONb STABILI'J:Ye RELEASEd NUMBER 
I· 
Volpo 20 Turbid 
Solulan 25 Cloudy 
Arlae·el 60 Cloudy 
Emerest 2400 Cloudy 
Emerest 2407 Cloudy 
Emsorb 2510 Cloudy 
Emsorb 2505 Cloudy 
Miranol CM Cone. Turbid 
Miranol HM Cone. Turbid 
Miranol H2M Cone. Turbid 
Miranol JEM Gone. Turbid 
Miranol L2M-SF Turbid 
Miranol 2MCA Modified Turbid 




Miranol S2M Cone. 













. TABLE 3 (CONTI:NUED) 






































































i i SURFACTANT 
I ; 
I , 












'I' ABLE 3 (CONTINUED) 










































































TABLE 3 (CONTINUED) 
a '+ g. Surfactant, 86 g. Solvent, 10 g. Propellant 12/11'+ (4oJ.so). 
b - + = foam production, - = no foam --production. 
c - + = greater than the time indicated. 
d - ++ = good, + = fair, - = poor. 
e - S = system separated. 
f - C = surfactant underwent clumping. 
g - 3P = three-phase separation. 
h - G = existence of gel prior to shaking. 
i - Poor textured foam, eliminated from future testing. 




information.. After formulation and agitation of' the product, 
the type of system: emulsified or clear non-emulsified was 
identified. The clegree and frequency of agitation and corres-
ponding emulsion stability were studied. The appearance of 
an emulsion can reflect the size of the dispersed droplets 
as reported by Griffin (35). A transparent emulsion may 
have a droplet size of 0.05 microns and smaller, a gray, 
semitransparent emulsion may have a droplet size of 0 .. 05 to 
0.1 microns, a blue-white appearing emulsion can have a 
droplet size of 0.1 to 1 micron, and a milky-white system 
can have a droplet size of greater than 1 micron. Sanders 
(11) has reported that most aerosol emulsions appear milky-
white, which indicates a droplet size greater than 1 micron .. 
Gross foam stability studies were conducted on foams 
·· having a stability of not less than thirty seconds. Foams 
of less than thirty seconds stability were considered to 
be non-foaming. These stability studies were conducted by 
discharging the foams onto three thicknesses of 20.5 em • 
.filter paper with 1.9 em. Roman letters stenciled on the 
top sheet. Gross stability time \•TaS recorded as that time 
when the letters could be read. Stable foams were arbi-
trarily established as foams remaining after eight hours. 
Foams of stability less than eight hours were eliminated. 
Valve release was also studied. Any marketable 
product systemmust possess these excellent valve release 
characteristics. Valve release tabulated in Table 3 was 
rated as: good (++), fair (+), and poor (-). Foam systems, 
67 
providing poor or fair characteristics were eliminated.o 
The pH number of each stable foam was recorded,. 
The t~rm, "pH number," has been used by Skoog and West (36) 
to describe pH values determined. by glass electrodes in non-
aqueous media. These pH numbers are arbitrary units and do 
not correlate with pH values obtained for aqueous media. 
These numbers are reported. for comparative purposes. The 
pH meter used was a Corning Model 7a equipped with a Semi-
Micro Combination Electrode with a 'l'riple-PUrpose Glass 
Membrane .. b The meter was calibrated using freshly prepared 
standard buffers.. The foams were discharged. into 50 mL. 
beakers and the glass electrode was inserted midway into 
the foams to record the numbers~ 
The foam systems were prepared by heating one third 
of. the solvent with the surfactant on a water bath. When 
solubilized, the mixture was added to the remaining two 
thirds of the solvent by vigorous geometric trituration in 
a suitable mortar. This concentrate was then placed in a 
Fischer-Porter aerosol compatibility tubec and fitted \vith 
a foam val~e.d Propellant filling was accomplished by use 
of a pressure flll apparatus,e suitably calibrated to provide 
a - Corning Scientific Instruments, Corning, N. Y. 
b - Coi-ning Glass Works, Medfield, Ma. 
c - ;'~scher and Porter Co., Warminster, Pa. 
d -''Clayton Corporation, Saint Louis, Mo. 
e :.;..General Kinetics Inc., Model GK-1200-L, Atlanta, Ga. 
the desired weight of propellanta by a timer device~ 
Selected Surfactant and Solvent Solubility' Screen~gg_for 
Inter]!le.diate and Quick~Break Fo,am ProductiQE_ 
1. Selected Solvept Solubilit~ Studies 
68 
For the production of intermediate and quick-break 
foams, a cosolvent must be added to a foam system producing 
a stable foam. This cosolvent must have properties ·v.rhich 
{l----~-~:e-enfrer-t--13.-e-s-B.-I'-f-ae-t-a-:at-s-e±-a-B-±-e-. -lPd.-r:'t-fl-ei'm-eP-e--,-t-fl-e-e-e-s-el-v-en+tT---------
must be completely miscible with the solvent in which the 
surfactant is insoluble. To test solvent-cosolvent 
solubility characteristics 5 ml. of solvent were mixed 
with 5 ml. of cosolvent in a test tube and agitated. r1is-
cibility was then noted. \vhere refractive indices vmre 
similar, 1 drop of 1 percent aqueous Amaranth Solution vias 
added to aid in phase separation detection. The results of 
these studies are tabulated in Table 4. 
2.. Surfactant, Solvent, and Cosolvent Combinations 
Capable of Intermediate and Quick-Bre~ Foam 
Production 
Surfactant-solvent-cosolvent combinations capable 
of intermediate and quick-break foam production were deter-
mined by examination of Tables 1, 3, and 4. If a sur~ 
factant and solvent are capable of producing a stable foam 
and if that surfactant is capable of being solubilized by 
a- E. I. duPont de Nemours and Co., Wilmington, Del. 
69 
TABLE 4 
SOLVENT-COSOLVENT MISCIBILITY STUDIES 
~USCIBI£ COf1BINATIONS 
A a I .. l'-1. b -
A P.,E.G. c -
• T")_rt d R. - .r..,u. 
P.E .. G. - P.G .. 
a - Alcohol U.S.Pe 
b - Isopropyl Myristate 
c - Polyethylene Glycol 400 U.S.P. 
d - Propylene Glycol U.S.P .. 
IMMISCIBLE COMBINATIONS 
r.r1.- P .. G. 
I.M. - P .. E.G. 
a cosolvent miscible with the solvent, then intermediate 
and quick-break foams can be producede Table 5 summarizes 
these s'urfactant-solvent-cosolvent combinations. 
3. TernarJ: Solubility Studies 
For all surfactant-solvent-cosolvent combinations 
appearing in Table 5, ternary solubility studies, using 
triangular coordinate graphing, were conducted. This pro-
cedure enablea. the production of surfactant solubility 
70 
curves from I'Jhich intermediate and quick-break foam formulas 
were obtained. 
The ternary solubility studies \'!ere cona.ucted using 
the following procedure. Dual titration, using 50 ml. 
burettes, was performed with three recorded weights of the 
surfactant di.ssolvecl in recorded amounts of the cosolvent. 
Each system was back-titrated with solvent until a cloud 
point - point of surfactant precipitation - was obtained. 
'I'he volume of solvent was recorded. Solubilization was 
re-established with a specific volume of cosolvent via 
titration. Several back titrations were performed for each 
weight of surfactant. During the titrations,· continuous 
stirring was maintained by use of a magnetic stirrera and 
barb set at a constant speed. All weighings were performed 
using an analytical balance.c A high intensity lampd and a 
a -La Pine Scientific Co., Chicago, Ill • 
. b Magnetic bar, 4 em. in length. 
c - Sartorius-\'/erke A 6, Gottingen, Germany. 
d - Sun Mark, Japan. 
TABLE 5 
SURFACTANT-SOLVENT-COSOLVENT COMBINATIONS CAPABLE 
OF INTERMEDIATE AND QUICK-BREAK FOAM PRODUCTION 
71 
SURFACTANT SOLVENT a COSOLVENT '6' 
Polawax A22 P .. G. c 
Pe-1--"awa~\:-A-3-1 T'l_/'1 .r.,u. 
Brij 72 P.G. 
Tegamine B-13 P.G. 
Tegamine S-13 P.G. 
Polawax A22 P.E .. G.e 
Polawax A31 P.E.G. 
. Tegamin.e S-13 P.E.G. 
a - Renders surfactant insoluble. 
b - Renders surfactant soluble. 
c - Propylene Glycol U.S.P. 
d Alcohol u.s.P. 










low pmver _ ma~nifying glass were used to aid in the detection 
of end points. The cloud point was arbitrarily established 
as that volume of solvent added to the examining vessel 
\'lhich so obscured the word, "Titration," typed on white 
paper surrounded by a black background, such that it could 
not be read. To check titration values, a second set of 
three weights of surfactant was titrated.. These three 
weights were the same weights of surfactant used initially .. 
Any surfactant-solvent-cosolvent for which data correlation 
could not be established 'ltTaS eliminated from further studies. 
If distinct end points were not obtained in the titration, 
the surfactalit-solvent-cosolvent was also eliminated. For 
these tvvo reasons the follm.ving vmre eliminated: Polawax 
,., A22-Propylene .Glycol-Alcohol, Polawa:x: A31-Propylene Glycol-
Alcohol, Tegamine B-13-Propylene Glycol-Alcohol, Tegamine 
S-13-Propylene Glycol-Alcohol, Polawax A22-Polyethylene 
Glycol 400-Alcohol, and Polawax A31-Polyethylene Glycol 400-
Alcohol. All values for volumes of solvents and cosolvents 
were averaged. Values were then converted to weights using 
specific gravities. These weights were converted to per-
centage weight and these percentage values were used in 
plotting the points on triangular coordinate paper. Repre-
sentative surfactant solubility curves were then drawn from 
these points. Titration data and corresponding graphs are 
shown by Tables 6 and 7 and Figures 3 and 4. 
TABLE 6 
TITRATION OF BRIJ 72-PROPYT.uENE GLYCOL-AL.COHO)L 
OBS. AV. OBS .. AV. \v/w TOJlAL PERCENT 
VALUESa VALUESb VALUESC V.lT. d. w/vje 
Br!j 72 Ll-.07 Ll-.07 4.07 4o07 14.46 28.16 
A. 10.0 10.0 10.0 8.16 56.44 
P.G.g · 1.9 2.4 2.15 2.23 15.40 
Brij 72 4.07 4.07 4.07 4.07 21.39 19.03 
A. 18.7 18.3 18.5 15 .. 10 70~56 
P.G. 1.9 2.4 2.15 2.23 10.41 
Brij 72 4.07 4.07 4.07 4.07 30.51 13.34 
A. 18.7 18.3 18.5 15.10 49.48 
P.G. 10.9 11.0 10.95 11.34 37.18 
Brij 72 4.07 4.07 4.07 4.07 33.29' 12.23 
A. 22.0 21.8 21 .. 9 17.87 53.69 
P.G. 10.9 11.0 10.95 11.34 34.08 
Brij 72 2.71 2.71 2.71 2.71 18.61 14.55 
A. 10.0 10.0 10.0 8 .. 16 43.85 
P.G. 7.4 7.5 7.48 7 .. 74 41.61 
Brij 72 2.71 2.71 2.71 2.71 23.22 11.66 
A. 16.0 15.3 15.65 12 .. 77 54.99 





Brij 72 2.71 2.71 
A.f g 16.0 15.3 
P.G. 18.5 17.5 
Brij 72 . 2.71 2.71 
A. g 19.0 18.3 
P.G. 18.5 17.5 
Brij 72 1.40 1.40 
A. 10.0 10.0 
P.G. 16.0 17.0 
Brij 72 1.40 1.40 
A. 12.5 12.3 
P.G • 16.0 17.0 
. -
TABLE 6 (CONTINUED) 

































59 .. 75 
a - Observed values _as g. of surfactant, ml. of solvent and cosdlvent. 
b - Average of observed values as g. of surfactant, ml. of solvJnt and cosolvent~ 
c - Average of w/w values as g., calculated using the specific J;ravities of the 
components. 
d - Sum of the three mean 'ItT/tv values as g. 
--..:1 .p-
e - Average w/w values expressed as a percentage of the total w~ight; these 
percentages were used in plotting points on Figure 3. 
f - Alcohol U.S.P. 























TITRATION OF TEGAI"'INE S-13-
POLYETHl~E GLYCOL 400-ALCOHOL 
OBS. AV. OBS. AV. w/trl 
VALUESa VALUESb VALUESc 
3.20 3.20 3.20 3 .. 20 
10.0 10.0 10,0 8 .. 16 
2.3 2.65 2.L~8 2 .. 78 
3.20 .· 3.20 3.20 . 3.20 
12.0 11.8 11.9 9 .. 71 
2.3 2.65 2.48 2 .. 78 
3.20 3.20 3.20 3 .. 20 
12.0 11.8 11.9 9.71 
3-3 3-7 3-5 . 3*94 
3.20 3.20 3.20 3.20 
13.7 13.5 13.6 11.10 
3-3 3-7 3 .. 5 3.94 
2.33 2.33 2.33 2 .. 33 
10.0 10.0 10.0 .8.16 
3-7 3.4- 3-55 3 .. 99 
2.33 2.33 2.33 2.33 
11.9 11 .. 5 11.7 9.55 
3-7 3.4 3-55 3.99 
TOTAL PERCENT 
WT.d "--l/vr8 

















25 .. 16 -....:J 0"1 
____________________________________ _.._ __ _. ________ ~---------=------~----~~~~~~,-~~--------~~~----------------------
TABLE 7 (~ONTINUED) 
OBS. AV. OBS. AV .. 1.1/v.I TOTAL PERCENT a VALUES 0 VALUESC WT.d v1/v18 VALUES 
-
Te~amine S-13 2•33 2.33 2.33 2.33 18 .. 01 12.96 
A. g 11.9 11.5 11.,7 9.55 53.00 
P.E.G~ 5.7 5.2 5 .. LJ-5 6 .. 13 34.04 
Tega.mine S-13 . 2.33 2.33 2.33 2.33 19.48 11 .. 98 
A. 13.4 13.6 13 .. 5 11.02 56.55 
P.E.G. 5.7 5.2 5.45 6 .. 13 31.47 
Tegamine S-13 1.86 1.86 1.86 1 .. 86 15.25 12.17 
A. 10.0 10.0 10 .. 0 8 .. 16 53.52 
P.E.G.o 4.8 4.5 L~.65 5 .. 23 34.31 
Tegamine S-13 1.86 1.86 1 .. 86 1..86 16.35 11.35 
A. 11.5 11.2 11 .• 35 9.26 56.65 
P.E.G. 4.8 4.5 4.65 5 .. 23 .32.00 
Tegamine S-13 1.86 1~86 1.86 1.86 18.88 9.83 
A. 11~5 11.2 11.35 9.26 49 .. 05 
P.E.G. 7.2 6.6 6.9 7.76 41.12 
Tegamine S-13 1.86 1.86 1.86 1 .. 86 20.80 8.92 
A. 13.9 13.5 13.7 11.18 53.75 
P.E.G. 7.2 6.6 6.9 7.76 37.33 
I . 








Average of observed values as g. of surfactant, ml. of sol"~rEmt and cosolvent. 
Average of w/w values as g., calculated using the specific Jravities of the 
components. 
d - Sum of the three mean w/w values as g. 
e - Average 'Vr/w values expressed as a percentage of the total 'l.'lEiight; these per-
centages were used in plotting points on Figure 4. 
f - Alcohol U.S.P •. 
g - Polyethylene Glycol 400 U.S.P. 
--.] 
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TE~~ARY SOLUBILITY STUDY 
OF ~3RIJ 72, PROPYLENE 
GLYG~OL U .S.P., AND ALCOHOL U .. S .. P. 
PerLnt w/w titration 
poit~ts (from Table 6) 
Forrrulation test points 




Poin~; # 2 
Alcohol U.S.P. --.J 
\.0 





Glycol 400 u.s.P. 
~~:cJ:\\ • Point # 4 
Point # 3 
Point # 7 
Point # 2 
FIGURE 4. 
TERNARY SOLUBILITY STUDY 
OF TEGArviiNE S-13, POLYETHYLENE 
GLYCOL 400 U.SoP., ~{D 
ALCOHOL U.s .P •. 
e 
.. 
= Percent vT/w titration 
points (from Table 7) 
= Formulation test points 
defined in Table 8b 
Point #16 
Pointl# 1 




J?.e.t~rmination and Evaluation of Prouosed Interme0.iat8 and 
Quic~-~reak Formulas for Foam Production 
Based upon the ternary solubility studies, only 
t\'10 systems produced surfactant solubility curves, Figures 
81 
3 and 4. These were: the Brij 72-l)ropylene Glycol-Alcohol 
system and the Tegamine S·-13-Polyethylene Glycol 400-Alcohol 
systeme The surfactants were insoluble in the glycols and 
produced stable foams. Both surfactants \'/ere soluble in 
Alcohol U.S&P. Alcohol and the glycols were miscible. 
Thus, the essential solubility criteria for the production 
of intermediate and quick-break foams were upheld& 
By examination of the ternary solubility graphs, 
regions of surfactant solubility and insolubility could be 
seen.. These graphs aided in the determination of formulas 
for the intermediate and quick-break foam systems. The 
graphic points, delineating surfactant-glycol-alcohol 
concentrations, ,,,.rere chosen. These concentration percent-
ages were then mathematically converted to represent 90 g. 
of the concentrate. The general formula t-lhich was used to 
test the production of these aerosol foams was as follows: 
Surfactant 4% w/w 
Glycol - Alcohol 86% 
Propellant 12/114 (40:60) 10% 
In the selection of representative formulation points, a 
concentration of 4.4 percent surfactant was used consis-
tently. This constant surfactant concentration can be 
seen on both Figures 3 and 4. This percent concentration, 
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when calculated, represented 4 g. of surfactant in the 90 g. 
product concentrate. The amount of propellant added \vas 
always 10 g., providing an aerosol foam test system of 100 g. 
Surfactant concentration \vas held constant so that only two 
variable£? would exist: the glycol and the alcohol concen-
trations. The points chosen for the production of inter-
mediate and quick-break test formulas were surfactant-
glycol-alcohol concentrations found near the solubility 
curve. These points have been numbered on the figures and 
are referred to in Tables 8a and b. Corresponding test 
formulas were determined, the systems were formulated and 
then tested for foam production. The formulation procedure 
was the same as that procedure described for stable foam 
production. System appearance, foam stability, valve 
release, and the pH number were recorded for successful 
formulas. The formulas and the test results have been 
summarized in Tables 8a and b. 
Antibiotic Aerosol Foam Formulation, Formation, and 
Evaluation 
Eight stable,. two intermediate stability, and t\'10 
quick-break foam vehicles were developed. other vehicles 
were formulated, but some of these were eliminated because 
of some undesirable property. These twelve foam producing 
vehicles.possessed potentially ideal properties for anti-
biotic incorporation. 
Four antibiotics commonly used in adjunctive dermal 
therapy were chosen. These antibiotics are commonly used in 
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commercially available ointments, creams, and lotions. These 
antibiotics include Neomycin Sulfate U.S.P., Polymyxin B 
Sulfate U.S.Pe, Gramicidin N.F., and Zinc Bacitracin UoS.P. 
All four antibiotics were incorporated into the proposed 
vehicles to determine if they adversely modified foam prop- · 
erties. This procedure eliminated duplication of formulations. 
Commercially available products generally contain 
Polymyxin, Bacitracin, and.Neomycin·or Polymyxin, Neomycin, 
and Gramicidin in combination. Neomycin Sulfate U.S.P. is 
a broad spectrum antibiotic used topically. It possesses 
bactericidal properties against various gram-positive and 
gram-negative organisms including Proteus strains (37,38)o 
Neomycin is very effective against ?taphlococcus aureu§_, a 
common etiological organism in topical infection., This drug 
is water soluble but solubility tests in Alcohol u.s .. P., 
Propylene Glycol, and Polyethylene Glycol 400 have indicated 
that it is only very slightly soluble in these three solvents. 
However, it is readily dispersible in the glycols. An 
"aqueous solution at pH ?.0 is thermostable, and may be auto-
claved at 120°0. for 10 minutes without inactivation11 (38). 
It is used topically in a concentration of 0.5 percent (3?). 
Therefore, each gram of product was formulat~d to contain 
5 mg. of the active ingredient. 
Polymyxin B Sulfate U.S.P. is a bactericide effective 
against gram-negative bacteria including Pseudomonas aeruginosa, 
a commonly encountered topical organism (38,39). The drug is 





• STABILITY SURFACTANT 
F0Af1S BRIJ 72 
. Point # 1 
: Graphic 96e 4.4 
I'est F9-rmula 
I (g.)-'- 4.0 
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TABLE 8aa 
PROPOSED INTElli~IATE AND QUICK-BREAK FORMU~ 
AND CORRESPONDING FOAM PRODUCTION RESULTS 
I 
--1: 
SOLVENT COSOLVENT PROPELLANT FOAH S~STEIVI 
P.G.b A.c P .. d PRODUCTION APPEARAJfCE 
Tjrbid 
67.0 28.5 --
60.3 25.7. 10.0 + 
i 
47.0 48.5 
42.3 43.7 10.0 - Cllear 
57.0· 38.6 
51.3 34.7 10.0 - Cllear 
62.0 33.6 
55.8 30.2 10.0 + T~~bid 
FOAr-1 VALVE pH 
STABILITY RELEASE No. 
12 hrs. ++ 8.0 
30 min. ++ ?,.?~ ( 
CP I 
-F 
··1'"111 "! ·· Tl 
! i . 
I .INTERJI'IEDIATE SURFACTANT 
: STABILITY TEGAJ.\1INE SOLVENT COSOLVENT 
FOANS S-13 ___ r_.~.g._.,:t), ______ A_._C 
I, 
'Point # 1 
1 :Graphic % 
;Test Formula 
(g.) 
1 Point # 2 
:Graphic 96 
1 Test Formula 
(g.) 
:Point # 3 
1 :Graphic % 
:Test Formula 
(g.) 
, Point # 4 








































SYSTEM FOAM VALVE pH 
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// • •'c •" 
1'1 
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'·Point # 5 
1
: Graphic % 
Test Formula 
(g.) 
1 Point # 6 
1 Graphic % 
Test Formula 
(g.) 




4.4 37.0 58.5 
4.0 33-3 52.7 
4.4 57.0 38.6 
4.0 51.3 34.7 
4.4 70.0 25.6 
4.0 63.0 23.0 
, a - Formulas derived from Table 6 and Figure 3 •. 
b- Propylene.Glycol U.S.P. 
c - Alcohol U.S.P. 














FOAM VALVE pH 
STABILITY RELEASE NO. 
20 min. ++ 7-9 
' e - The weight-weight percentages of the surfactant, solvent, and cosolver~t, derived f'rom the respec-
tive graphic point specified. (X) 
()'\ 
f - The test formula expressed in g. derived .from the respective graphic ~~oint specified. 
1 
g - Formulas derived from Table 7 and Figure 4. 
I 
1 






is capable of being dispersed in Propylene Glycol and 
Polyethylene Glycol L~OO and has been found only partially 
soluble in these solvents. A solution of this antibiotic 
remains stable for a year at temperatures 0 up to 38 c., at 
a pH of 6o0 to 7.0 and is autoclavable at 120°c .. for five 
minutes (40). Topical solutions contain 0.1 to Oo25 per-
cent of this antibiotic., Polymyxin B Sulfate Ointment u.s.P. 
contains 20,000 units per gram (39).. Commercially avail-
able triple antibiotic ointments or creams contain 5,000 to 
10,000 units per gram. Each gram of foam product has been 
formulated to contain 10,000 units of Polymyxin B Sulfate .. 
Gramicidin N.F. is active against most gram-positive 
bacteria including hemolyti~ :s:trep:t_ococci. It possesses 
both bactericidal and bacteriostatic properties. The anti-
biotic is insoluble in water, soluble in alcohol, and it 
has been found to be soluble in the two glycols used in the 
above formulationse Topically, it is employed in a con-
centration of 0.05 percent (LJ-1). Triple antibiotic creams 
use a concentration of 0.25 mg. per gram of cream. This 
same concentration \vas incorporated into each gram of foam 
product. 
Zinc Bacitracin U.S.P. is a bactericidal and bacteria-
static antibiotic effective topically against a variety of 
susceptible gram-positive organisms including Staphylococcus 
aureus (42). It is sparingly soluble in water (43), slightly 
soluble in alcohol, and only partially soluble in Propylene 
Glycol and Polyethylene Glycol 400. Zinc Bacitracin can be 
used in formulations requiring heat (4L~). Zinc Bacitracin 
is used topicall3r in ointments containing 400 to 500 units 
per gram. Each gram of product formulated contained 400 
units of Zinc Bacitracin. 
These antibiotics in combination have been found 
effective in primary pyodermas, secondary infected derma-
toses, traumatic lesions, and in prophylaxis of "cutdovm" 
infections, burns, skin grafts, and incisions ( L~-9). All 
of these antibiotics have synergistic bactericiclal prop-
erties and provide overlapping activity. In reference to 
surface infection Panaccio {5) has stated that "the 
synergism of antibiotics has been investigated during the 
past several years, and combinations have been found to 
give better results than the use of a single antibiotic." 
The twelve antibiotic containing test formulas 
for foam production are shown in Table 9. The procedure 
used in formulation of the t\'lelve systems is the same 
as that procedure described in formulation of the stable 
foam vehicles. Hm~ever~ the antibiotics \v.ere dispersed 
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in the two thirds portion of solvent by geometric incor-
poration using a mortar. The one third solvent-surfactant· 
mixture heated on the water bath \>las allmV"ed to cool to 
room temperature before the addition of the antibiotic-
glycol dispersion. Alcohol \'Tas added to the appropriate 
formulations at the end of the incorporation ;procedure. 
The formulations \'!ere charged in either aerosol compati-
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TABLE 9 ( CONTII:ruED) . 
': 
lll•l:i'•lr'l I 'il lr L. __ j 
b - Propylene Glycol U.S.P. 
c - Propellant 12/114 (40:60). 
d - Polymyxin B Sul.fate U.S.P., Zinc Bacitracin U.S.P., Neomj1cin Sul.fate U .S.P., 
Grai!licidin N.F. 





The twelve formulations were then tested for the 
follovling physical properties: bulk density, percentage 
discharge, percentage overrun, relative viscosity~ and 
system pressure. The system appearance, foam appearance, 
.foam texture, foam feel, and valve release were also noted. 
Stability tests \vere also conducted indicating gross sta-
bility~ percentage drainage, and wetting properties .. 
1. Bulk Den~i t_x 
Bulk density is the experimentally calculated value 
for the test material which would also include the intra-
particular pores and void spaces bet\veen particles ( 45). 
This definition is well adapted to foam densities. ~~he 
bulk density indicates the weight of .foam discharged per cc. 
of foam delivered as well as the degree of aeration. In 
comparing a series of foams, density is a useful property. 
A stable foam should possess a higher density than should 
a .foam of limited stability. Nevertheless, the higher 
density foam in a given stability type is desirable. The 
procedure employed in determining the bulk densities utilized 
35 ml. weighing bottles. Each bottle was tared for its 
weight on an analytical balance and its volume determined. 
Each .foam system was carefully discharged into the weighing 
bottle using an 8.9 em. nozzle extension to provide .for 
uniform filling. As the foam was discharged, the nozzle 
a- Continental Can Company, Inc., Chicago, Ill. 
was maintained just above the foam layers to assure uniform 
filling. After the foam was- discharged, 15 to 30 seconds 
were allowed for foam expansion and then the excess foam was 
remov-ed with a spatula (11). The bottle was then stoppered 
and weighede The foam weight was divided by the respective 
volume of the bottle. The bulk density was then calculated 
and expressed in grams per cubic centimeter. At least three 
determinations per foam were conducted and the results aver-
aged. These values are summarized in Table lOe 
2. ?ercentag~ Discha~ 
The percentage discharge of a foam product is an 
important criteria for marketability~ It is directly related 
to the percentage of propellant and its vapor pressure (46)~ 
For non-pharmaceutical foams Root (46) has stated that with 
a properly formulated product, values of 90 to 95 percent 
should be expected. For the antibiotic foams tested., values 
less than 88 percent eliminated that test formulation. The 
procedure used in determining the percentage discharge con-
sisted of weighing the aerosol container and valve assembly 
before and after product filling and again after the total 
contents had been discharged. Appropriate calculations were 
made and the average values of at least three determinations 
per f.oam are also summarized in Table 10. 
3. Percentage Overrun 
Another important factor in aerosol foam products 
is the percentage overrun. "Overrun is a measure of the 
change in volume that occurs when an emulsion of a liquefied 
95 
gas propellant is allowed to expand into a foam" (11). 
The equation given by Root (L~6) for percentage overrun is: 
% Overrun :::: _v_o_l_u_m_e_o_f'_F __ I o.....;a..;..r_n ~-V_o_l_;.u_m--'-e_o_f_L_i_,q_u_i_d_ X 100 
Volume of IJiquid 
This factor is governed by formulation and propellant con-
centration (46). Foams ·v.rith high percentage overruns (1000 
percent) are desirable but must be judged in reference to 
their respective foa_lll_~_!_<.:t~.lj:!_l__~y_p~~----~he __ V_()l~~e _oj the 
foam described in the above equation is determined from 
direct reading of the expanded foam volume in a suitable 
volumetric vessel.. The volume of liquid is the volume of 
the emulsion system under pressure. Using suitable nozzle 
extensions, each foam was discharged into a 100 ml. cylin-
drical graduate and the resultant volume of foam, produced 
a.fterexpansion, was recorded in·ml. The volume of the 
emulsion in the aerosol compatibility tube was recorded 
before and after each discharge. These.volumes obtained 
from the compatibility tube scale \'Jere calibrated and con-
' 
verted to ml. At least three tests were performed on each 
foam and the results were averaged. These results are 
found in Table 10. 
4. yiscosity 
Viscosity is a rheological property \.vhich measures 
fluid friction or resistance to flO\'J. Fluid friction is 
produced when one layer of fluid moves relative to another 
layer. Thus, viscosity may be considered as an internal 
friction produced as fluid layers are sheared. The force 
. l-
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(in dynes) per unit area (in em.) produces the shearing 
action which is called shearing stress. The rate of shear 
measures the speed at which the layers move with respect 
to each other. It is the rate of change of velocity (in 
em. per second) vJith respect to the change in distance (in 
em.). Viscosity is defined mathematically as the shearing 
stress divided by the rate of shear.. A fluid requiring a 
shearing stress of 1 dyne per cm~ 2 and producing a rate of 
I~----- ---;,h_e_a_r_ of--on_e __ i_n_v_e;-s e--s-~co~d -h~~-a--;i~-~ o~ it-~- ~f- i -p~is~-;;--- -- -
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cosity as the shearing stress is changeo_, are termed 
Ne\vtonian. Materials \·Jhich do not exhibit these ideal 
properties are called non-Nevrtonian. Foams display non-
Newtonian characteristics and exhibit thixotropic-like 
properties, since they become fluid \IJhen shaken. Relative 
viscosities of undisturbed foams serve as comparative 
rheological properties for a series of foam products. When 
viscosities are reported, it is imperative that temperatures 
at which the viscosities are obtained, be also recorded. An 
inverse relationship exists such that any increase in tem-
perature w:lll result in a corresponding decrease in viscosity. 
For a one degree centigrade change in temperature, there is 
an approximate 10 percent change in viscosity (47). 
The Brookfield Synchro-lectric Viscometera and accom-
panying Brookfield Helipath Stand b \llere used in the 
a - Brookfield Engineering Labs., f\1odel LVT, Stoughton, Ma. 
b- Brookfield Engineering Labs., Model C, Stoughton, Ma. 
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determination of viscosityo The calibrated T bar type 
spindles were also used in these analyses. The Brookfield 
Viscometer is a rotational type of instrument. Viscosity 
is determined by the torque produced on a spindle rotating 
at a constant speed. as measured by a beryllium-copper, 
calibrated_ spring. The spindle or T bar is allowed to 
rotate in the test foam.. The position at which the pointer 
stabilizes on the viscometer dial is the reportable reading 
in centipoise. This value must be corrected by a factor 
'ltlhich is a function both of the angular velocity and the 'I' 
bar used. 1.rhe Helipath stand enables 11 consistent measure-
ments in relative centipoise.values of materials having 
characteristics similar to grease, putty, shaving cream, 
toothpaste, gelatin, or wax 11 (49). Thust this apparatus 
serves \vell for aerosol foam analyses., The stand allo'I;IIS a 
spindle in the form of an inverted T to make a helical path 
through the test material such that the bar constantly 
encounters ne\'l material and leaves that which its previous 
motion has disturbed (48-51). Each foam was discharged 
into a 250 ml. beaker. The viscometer and Helipath stand 
were suitably adjusted with the viscometer guard removed. 
The extra weight provided with the T bars was also attached 
to the chuck and closer coupling assembly and used through-
out all determinations. Average values of t\'lO or three 
determinations per foam "'ere recorded along with the tem-
perature, speed, and T bar used. All average relative 
















ANTIBIOTIC AEROSOL FOAM EVALUATION: DENSITY~, 






DENSITYb DISCHARGEC OVERRUNdi 
I 
,I 
0.14-6 90.64- 684- I 
0.151 88.31 751 
0.167 85.31 4-00 
0.129 89.67 622 
0.197 89.32 634-
0.129 96.87 531 
0.163 97.16 399 
0.147 92.85 834-
0.165 90.61 938 
0.180 88.33 211 
0.188 89.66 474 













8,512m \,..() OJ 
TABLE 10 (CONTINUED) 
a - The formula numbers refer to those formulas proposed in Talble 9. 
b - The average of at least three values expressed in g./cc. 
c - The average of at least three values expressed in %. 
d - The average of at least three values expressed in %. 
e - The average of two to four values expressed in centipoise. 
f of viscosity measurements: T-Bar F, Speed 0.6 :rpm., Conditions 
22.o0c. 
g - Conditions 
22.o0 c. 
of viscosity measurements:· T-Bar F, Speed 0.3 1rpm .. , 
I 








i Conditions of viscosity measurements: 
22.ooc. 
T-Bar B, Speed 0.,6 :rpm .. , Temperature 
I 
j - Conditions of viscosity measurements: 
22.5°C. 
k - Conditions of viscosity measurements: 
22.5°C. 
1 - Conditions of viscosity measurements: 
22.5°C. 
m - Conditions of viscosity measurements: 
23.0°c. 
I 
T-Bar F, Speed 0 ... 6 'rpm., Temperature 
I 
' 
T-Bar C, Speed 0. 3 :rpm., Temperature 
I 
! 
T-Bar C, Speed 0.6 1rpm., Temperature 










5. pystem Pressure 
The vapor pressure of a blend of' Propellant 12 -
Propellant 114 in a LJ.Q: 60 weight-weight ratio is 35.1 psig. 
at 70°F. as calculated by Sanders (11). Using a pressure 
gaugea the foams were tested for total internal pressure 
in the aerosol system. The values obtained were not greater 
than 40 psig .. 
6. Miscellaneous Tests 
The system appearance, foam appearance, foam texture, 
foam feel, and valve release for the foam systems were also 
observed. The results are recorded in Table 11 .. 
7. Foam ptabilitx 
Foam stability may be studied by considering any 
factors relative to the inverse phenomenon of foam breakdown. 
Since foam systems are thermodynamically unstable, breakdmvn 
is ari.·inherent property. Breakdovm results from propellant 
bubble coalescence and from liquid drainage. By studying 
foam drainage, wetting, and collapse for each foam produced 
in the series of proposed formulas, a comparative means for 
foam stability analysis would exist. 
Foam drainage \vas analyzed by the follot,ring method. 
Each foam aerosol was discharged into a 75 mm. filtering 
funnel possessing an average volume of 95 ml. Liquid drain-
ing from the foam \'ras. collected in a 50 ml. graduated 
cylinder~ At the end of 24 hours, the volume of collect 












.ANTIBIOTIC AEROSOL FOAM EVALUATION: SYSTEI1 APPE.AJ.RANCE, 




SYSTEr1 b FOAM FOAT1 
APPEARANCE· APPE.AR.ANCEc TEXTUREd FE:ELe 
I 
'i 
White, Good, Thick, Fine Exotb!ermic 
Cloudy Creamy Emoll.ient 
I 
I 
White, Good, Thick, Fine ExotHermic 
··Cloudy. Creamy EmolJJient 
I 
vlhite, Good,. Thick, Fine 
I H'v- .... , ' • 
~J>.o u.nerm~c 
Cloudy Creamy EmolJJ.ient 
I 
\·lhite, Good, . Coarse Exot}j_ermic 
Cloudy ·creamy Emoll~ient 
I 
\>Jhite, Thick, Good, Very Fine E".Aot~.ermic 
Cloudy Thick, Creamy EmolJJ.ient 
'fui te, Fluid, E'.Apanding Coarse 
Cloudy Emollient 
I 
\vhite, Fluid, Thin,· Medium 




Good, Thick, Fine Exot!iermic 














!-' ++ 0 
!-' 




SYSTEM FOAM d FG.Ar-1 
FORMULA a APPEARANCEb APPEARANCEc 






Good, Thick Fine ExotY.termic 
9 Cloudy Creamy Emolj_ient 
I 
White, Thick, Creamy I1ediUIIl ~ . r . 'CO"C termlc 
10 Cloudy Emoltient 
I 
I 
White, Cloudy, Fair Medium I 
11 Clumpy Gritf;y 
I 
11/hite, Good Medium I 
i 
12 Cloudy Emollient 
I 
a - The .formula numbers refer to those formulas proposed in Table 9 .. 
b- The appearance o:f the aerosol system under pressure in anlaerosol 
compatibility tube. 
c - The appearance of the discharged product after one minute., 
d - The texture of the bubble matrix. 
e - The feel of the foam when rubbed in the palm of the hand. 
f - ++ = good, + = fair, and - = poor release -- only producti~ \'lith good 











was recorded and the data converted to percentage drainage 
by the following formula: 
·----V~o~l~u~m~e~o~f~:_C~o~l~l~e~c~t~------ X 100 = % Drainage per 24 bourse 
Volume of Funnel Reservoir 
If no drainage was recorded in 24 hours, the tests were con-
tinued for a total of l~8 hours. Three determinations per foam 
were conducted and the results were averaged. These values 
r.------a-ppear-in-Table-12-.. ------------------- ______________ . _____________________ _ 
Foam wetting is another stability factor which may 
be determined by the follO\ving procedure.. Each aerosol foam 
was discharged into a 15 dram plastic prescription vial v1hose 
base was removed.. The volume of the vials was determined to 
average L~3 .. 5 ml., After vvaiting one minu:t:e for foam expan-
sion, excessive foam residue was removed \vith a .spatula and 
the plastic cap placed loosely on the viaL, The vials rested 
on two layers of 20.5 em. filter paper. After 24 hours, four 
perpendicular radii \'rere recorded indicating the distance 
from the center that the liquid in the foam had moistened 
the filter paper. These values were averaged ana. the total 
area \vet·t;ed \V'as calculated. The actual area wetted was 
determined by subtracting the area of foam discharge from 
the total area wetted. Three determinations were conducted 
per foam tested and the results were averaged. These values 
appear in Table 12. 
Foam collapse was also recorded. As performed pre-
viously for gross stability studies, the total time for 
foam collapse was recorded. The same procedure was used 
a.s described in the evaluation of proposed stable foam 
formulas. Stability greater than 24 hours was reported 



















ANTIBICY.riC AEROSOL FOAM EVALUATION: FOAM. STABI~riTY 
PERCENTAGE AVERJ,_GE ACTUAL 
GROSS STABILITYd DRAINAGEb AREA \VETTEDc 
1.4%/24 hrs. 73 .. 7 +24 hrs. 
Ie/48 hrs. 8.6 +24 hrs. 
2.196/48 hrs. 64.L~ +24 hrs. 
8. 796/24 hrs. 120 .. 6 24 hrs. 
0 %/48.hrs. 3.3 +24 hrs. 
6.396/24 hrs. 67. 1+ 12 hrs. 
15.496/24 hrs. 105.0 30 min. 
1.196/24 hrs. 47.4 +24 hrs. 
2.196/48 hrs. 4l~.8 +24 hrs. 
7-996/24 hrs. 145.9 ! 18 hrs. 
9. 396/24 hrs. 124.7 10 hrs. 




TABLE 12 ( CONTI1"1JED) 
I 
a - The formula numbers ref'er to those f'ormulas pronosed in Ta!ble 9 .. 
. • I 
b - The average of' at least three values per 24 or 48 hours e}jpressed 
as percent. I 
. 2 .I 
c - The average of' at least three values expressed in em • 
d - A plus bef'ore a time -yalue indicat~s a time interval greatl
1
er than 
that value expressed ~n hours or minutes. 






The screening of surfactants provided useful 
information for the production of stable aerosol foams .. 
Of the 60 non-aqueous glycol foam systems analyzed, 68 
percent produced foams of varying stability. T\,renty-six 
For the Isopropyl .Nyristate and Alcohol u .. s.,P .. foam sys-
tems analyzed, no foams were produced.. It is proposed 
that these systems provided emulsion concentrate densities 
too low (less than one) to structurally support solid 
stabilization of the foams.. Increasing the concentration 
of the surfactant or adding other solvents to increase the 
emulsion concentrate density might enable foam production 
from these systems. The glycol foam systems provided con-
centrate densities greater than one and adequately supported 
solid stabilization for foam production. General surfactant 
solubility analyses and subsequent stable foam formulation 
attempts proved successful as a screening procedure for the 
determination of ideal stable foam vehicles. 
The ternary solubility studies and the correspond-
.ing solu"Qility graphs were utilized effectively for the 
production of intermediate and quick-break foam vehicles. 
These solubility graphs enabled a logical approach to the 
production of "limited stability" foam formulas. Eleven 
formulas '\'.rere attempted and five of these produced 
desirable 11 limited stability 11 foams. Of the eight 
surfactant-solvent-cosolvent combinations previously 
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listed in Table 5 for the production of intermediate and 
quick-·break foams, only t\•TO of these combinations produced 
successful ternary solubility studies. This resulted from 
the difficulty encountered in the analysis of titration 
end points.. If another titration procedure using a dif-
ferent; solubility end point analysis \•ms possible, the 
yield of successful ternary studies and resultant "limited 
stability 11 foam systems '\'JOuld be augmented. 
T\•Tel ve foam vehicles were selected for the inc or-
poration of the chosen antibiotics. Eight stable, two 
intermediate stability, and two quick-break foam vehicles 
possessed desirable foam system prope:~.--ties. The anti-
biotics '1/Tere successfully incorporated into these vehicles. 
The foam vehicles, themselves, \'lere not extensively analyzed 
as were the corresponding antibiotic foam systems. The 
emulsion properties of the vehicles \·Jere \'lell sui ted for 
the incorporation of the relatively small amount of medica-
ment. Should incorporated antibiotics have adversely affected 
a .foam vehicle,. this effect \·iould have appeared in the exten-
sive screening o.f the antibiotic .foams themselves. 
The analyses of the t...:mlve antibiotic aerosol foams 
shown in Table 9 \·rith the subsequent evaluation of the prop-
erties as listed in Tables 10, 11, and 12, proved useful. 
A percentage discharge of at least 88 percent is an economic 
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necessity for any aerosol foam, since undispensed foam 
provides no therapeutic or economic benefit. 
For an ideal antibiotic foam, a high density is a 
desirable property. The antibiotic foam o:f higher density 
provides a ,greater 't:might of foam per unit volume of foam 
discharged. With a greater weight of foam delivered per 
unit volume, corresponding therapeutic concentrations of 
the incorporated antibiotics would be supplied to a 
specific site by a smaller volume of discharged foamo 
Hence, from a therapeutic and economic standpoint, a high 
density pharmaceutical foam is idealo Conversely, should 
a low density antibiotic foam be used topically, a larger 
foam volume must be dispensed to provide a therapeutic con-
centrationo Should the application site be small, thera-
peutic amounts of the antibiol;ics could not physically reach 
the area. Therapeutically, such a risk is unfoundecl. If a 
high density antibiotic foam is to be applied to a large 
area, more foam must obviously be applied. Nevertheless, 
this economic consideration is far outweighed by the 
therapeutic consideration. Commercially available anti-
bio·bic ointments and creams are also governed by this pre-
requisite. Thus, a high density is mandatory. 
Relative to foam density is the percentage overrun 
of a foam. A large percentage overrun is economically 
desirable, since this reflects a large volume of delivered 
foam relative to the volume of pressurized emulsion .from 
which the foam is produced. Here again, therapeutics must 
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take precedence over economics. Antibiotic foams providing 
overruns less than the 1000 percent value established for 
non-pharmaceutical foams must be judged carefully. Further-
more, the antibiotic foams must be judgeQ. in reference to 
their stability classification. As the foam stability 
decreases, the corresponding percentage overruns may also 
decrease, since the cosolvent present in the formulation is 
present to increase foam pressure sensitivity and breakdoi'm .. 
Thus, lOI'Jer percentage overruns may be expected for anti-
biotic foams6 Values of 400 to 1000 percent were arbitrarily 
deemed acceptable in this study .. 
The viscosity of a foam is related to its ability 
to be spread over a surface. The higher the viscosity, the 
less the ease of spreading. HO\'lever, for every 1°0. increase 
in the temperature, there is an approximate 10 percent 
decrease in viscosity and increase in spreadability. Thus, 
a high viscosity antibiotic foam is desirable, since body 
temperature can decrease foam viscosity by as much as 170 
percent. 
The ideal antibiotic foam should be a highly stable 
foam. As with viscosity, the body heat of the application 
site will greatly increase foam breakdovm and drainage. 
Therefore, a lm'l percentage drainage, a small area wetted, 
and a high gross stability would be ideal for an antibiotic 
foatn. 
A fine foam texture is a desirable property for anti-
biotic foams. A fine foam possesses a greater surface area 
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and has better penetration potential. A non-gritty foam 
with emollient properties is essential for topical use and 
a foam \vi th exothermic properties is desirable, since 
increased hemodynamics to an infected or traumatized appli-
cation site would facilitate increased healing. 
By examination of Tables 10, 11, and 12, one is able 
to screen the twelve antibiotic foams for ideal properties~ 
Four stable foams possessed the greater number of ideal 
characteristics. Formulas 9, 5, 2, and 8 in order of 
decreasing merit, were the most desirable of the eight 
stable foam formulations. Of the t\vO intermediate and the 
two quick-break foam systems, Formulas 6 and 7 provided the 
most suitable properties in their.respective foam stability 
classifications. All foams were screened for the ideal 
antibiotic foam properties outlined in the above discussion. 
The surfactants utilized in Formulas 2, 8, and 9 were identi-
fied chemically as propylene glycol monostearate (self-
emulsified). Formulas 2 and 9 used the product labeled 
Tegin P, whereas Formula 8 used the product labeled Emerest 
2381. Any discrepancies in solubility, foam, or evaluation 
characteristics may be attributed to differing manufacturing 
procedures or standards. Tegin P is available from the manu-
facturer in a lump form, i·Jhereas Emerest 2381 is available 
in a granular form. Formulas 5, 6, and 7 used the surfactant, 
Brij 72, a polyoxyethylene (2) stearyl ether. 
Both propylene glycol monstearate (self-emulsifying) 
and polyoxyethylene (2) stearyl ether are nonionic surfactants 
and thus provide minimal skin irritation properties$ 
Sanders (11,22,25) found ethoxylated fatty alcohol sur-
factants of lov; ethylene oxide content and propylene 
glycol monostearate (self-emulsifying) to be excellent 
surfactants for the non-aqueous glycol foams. Brij 72 
is an ethoxylated fatty alcohol of low ethylene oxide 
content, described by Sanders (11,22,25) as effective in 
foam production. Polawax A-31, an ethoxylated stearyl 
----
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aicohor;-:rs-another- nonionic surfactant of the ethoxylated 
fatty alcohol series. Sanders (11,22,25) described this 
agent as one of the preferred surfactants for non-aqueous 
glycol foams.. In this project, Formula 1 used Polawax A-31, 
but it was found to provid.e antibiotic foam properties less 
desirable than those of Tegin P or Brij 72e 
SUMMARY AND CONCLUSIONS 
The following objectives were accomplished in this 
project: 
l. An arbitrary series of surfactants were success-
fully scr~ened for their solubility in Alcohol U.SoP., 
:---------;I-sepPGpy-1-My-r-istate-,--:t>l.l~if'ied-Wa-tei'-u .. s .. r:> .. ;-Eolyethorl ene------------ -
Glycol 400 U.S .. P., and Propylene Glycol U .. S.,P.; 
2.. Stable non-aqueous glycol foams \'Tere formulated 
and produced on the basis of the solubility studies using 
the theory of solid stabilization of foams; 
3.. Surfactants producing stable foams were titrated 
with appropriate solvents and cosolvent and two ternary solu-
bility graphs were produced, representing the Brij 72-
Propylene Glycol-Alcohol U.S.P. system and the Tegamine S-13-
Polyethylene Glycol 400-Alcohol U.S.P. system; 
4. Two intermediate and two quick-break foams were 
produced using formulas derived from the above ternary solu-
bility studies; 
5. Therapeutic concentrations of Neomycin Sulfate 
U.S.P., Polymyxin B Sulfate U.S.P., Gramicidin N.F., and 
Zinc Bacitracin U.S.P. were successfully incorporated into 
the eight stable, two intermediate, and two quick-break foam 
vehicles possessing excellent foam characteristics; 
6. The twelve antibiotic foams were analyzed for 
ideal physical and stability properties and the most desirable 
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antibiotic foam formulas were determined. 
This project provided a logical approach to the 
development of ideal antibiotic foams designed for topical 
use. The most desirable stable foams are represented by 
Formulas 9, 5, and 2. 
:wormulaa 9 Formula a 5 Formula a 2 
Tegin P 4 .. 0 g$ Brij 72 lJ .• O g. Tegin P 4.0 
P.E.G.b 86.0 P.G. e 86.0 e P .. G. · 86.0 
g .. 
-------- -- - ------- - -- ----
Propellantc 10.0 Propellantc 10.0 Propellantc 10 .. 0 
P.B .. N .. G .. d 1.5 P.B .. N.G.d 1.5 P.B.N .. G. d 1.5 
The most desirable intermediate and the most desirable quick-
break foams are represented by Formulas 6 and 7 respectively. 
Formula a 6 Formula a 7 
Brij 72 4.0 g. Brij 72 4.0 g. 
P.G. e 60.3 P.G. e 55.8 
Alcohol 25.7 Alcohol 30.2 
Propellantc 10.0 Propellantc 10.0 
P.B.N.G. d 1.5 P.B.N.G. d 1.5 
These five antibiotic foam systems possess ideal physical and 
a - All ingredients in each formulation are expressed on a 
weight-vTeight basis. 
b - Polyethylene Glycol 400 U.S.P. 
c - Propellant 12/114 (40:60). 
d- Polymyxin B Sulfate U.S.P., Zinc Bacitracin U.S.P., 
Neomycin Sulfate U.S.P., Gramicidin N.F. 
e - Propylene Glycol U.S.P. 
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stability properties representative of their respective 
stability classification and thus provided the most poten-
tial as antibiotic aerosol foams .. 
It is suggested that further testing of these five 
potential antibiotic foams be performed. Extended shelf 
stability studies, comparative antibiotic release studies, 
toxicity tests, and in vitro and in ~ efficacy stud.ies 
must be accomplished before these products can be con-
-ll------------ -------- ------------- -- ---- ----- ---- -- -- -- --- --- -- ------- --------- --- ---- --------
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